Anesthesia & Analgesia
March 2004
Table of Content
«D¤ßŦ¤â³N³N¤¤¤ß¦åºÞ¨Æ¥óªºµo¥Í²v¤Î¦Û°ÊÀË¥X²v
(¤èªÚ Ķ Á§±iºõ ®Õ¡^
The Incidence and Prediction of Automatically Detected Intraoperative Cardiovascular Events in Noncardiac Surgery
Rainer Röhrig, Axel Junger, Bernd Hartmann, Joachim Klasen, Lorenzo Quinzio, Andreas Jost, Matthias Benson, and Gunter Hempelmann
Anesth Analg 2004 98: 569-577.
³N«eªA¥Îªü´µ¤ÇªL¯f¤H¹w¨¾©ÊÀ³¥Î¥h®ò¥[À£¯À¨Ã¯à¤£´î¤Ö«a¯ß¤â³N«á¥X¦å¶q
(¤ý¥ß¤¤Ä¶¡@ §õ¤h³q®Õ¡^
Prophylactic Treatment with Desmopressin Does Not Reduce Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Before Surgery
Hilde Pleym, Roar Stenseth, Alexander Wahba, Lise Bjella, Arve Tromsdal, Asbjørn Karevold, and Ola Dale
Anesth Analg 2004 98: 578-584.
CABG³N«á§Z¶ê¤Õ¥¼³¬©M¤ß©ÐŸ°Êªº¬ÛÃö©Ê
(»ôªi¡@Ķ¡@¡@¤ý²»·ç¡@®Õ¡^
The Association of Patent Foramen Ovale and Atrial Fibrillation After Coronary Artery Bypass Graft Surgery
George Djaiani, Barbara Phillips-Bute, Mihai Podgoreanu, Robert H. Messier, Joseph P. Mathew, Fiona Clements, and Mark F. Newman
Anesth Analg 2004 98: 585-589.
ÀR¯ß¨Ï¥Î²m¤þ©K¤T嗪ªvÀø³æªÍ³q®ðªº§C®ñ¦å¯g
(¤èªÚ Ķ Á§±iºõ ®Õ¡^
Treatment of Hypoxemia During One-Lung Ventilation Using Intravenous Almitrine
Nicolas Dalibon, Marc Moutafis, Ngai Liu, Jean-Dominique Law-Koune, Stéphanie Monsel, and Marc Fischler
Anesth Analg 2004 98: 590-594.
°ª®ñ¼W±j²§¤þ×ôµÎ±i«aª¬°Ê¯ßªº§@¥Î
(°¨µqµY
Ķ¡@ §õ¤h³q ®Õ¡^
Amplification by Hyperoxia of Coronary Vasodilation Induced by Propofol
Alexandre Ouattara, Gilles Boccara, Patrick Lecomte, Rachid Souktani, Philippe Le Cosquer, Stéphane Mouren, Pierre Coriat, and Bruno Riou
Anesth Analg 2004 98: 595-603.
®a¨ßÀ³¥Î¤û·½©Ê»E¦X¦å¬õ³J¥Õ¹ï°Ê¯ßªº¦å®ê§Î¦¨©M¥X¦åªº§@¥Î
(»ôªi¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
The Effects of a Polymerized Bovine-Derived Hemoglobin Solution in a Rabbit Model of Arterial Thrombosis and Bleeding
Emmanuel Marret, Philippe Bonnin, Elisabeth Mazoyer, Bruno Riou, Ted Jacobs, Pierre Coriat, and Charles-Marc Samama
Anesth Analg 2004 98: 604-610.
(¤èªÚ Ķ Á§±iºõ ®Õ¡^
Clinical Evaluation of the Effects of Signal Integrity and Saturation on Data Availability and Accuracy of Masimo SET® and Nellcor N-395 Oximeters in Children
Frederick A. Robertson and George M. Hoffman
Anesth Analg 2004 98: 617-622.
¨àµ£ÁB§Î¤j¤â³N³N«á«ùÄò¸y¦Ù¶¡«Çªýº¢Âíµh¡G¤@¶µ«e¤©ÊCT±½´y¤ÎÁ{§É¸ÕÅç
(©P§Ó°íĶ §õ¤h³q®Õ¡^
Continuous Psoas Compartment Blocks After Major Orthopedic Surgery in Children: A Prospective Computed Tomographic Scan and Clinical Studies
C. Dadure, O. Raux, P. Gaudard, M. Sagintaah, R. Troncin, A. Rochette, and X. Capdevila
Anesth Analg 2004 98: 623-628.
¤þªy×ô¡B²§¬tîÅ¡B¤C¬tîÅ©M¦a¬tîÅ«D¦í°|³Â¾K«á´_Ĭ±¡ªpªº¤ñ¸û¡G¤@¶µ¨t²Î©Ê¦^ÅU¬ã¨s
(®ï¤å²W¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Comparison of Recovery Profile After Ambulatory Anesthesia with Propofol, Isoflurane, Sevoflurane and Desflurane: A Systematic Review
Anil Gupta, Tracey Stierer, Rhonda Zuckerman, Neal Sakima, Stephen D. Parker, and Lee A. Fleisher
Anesth Analg 2004 98: 632-641.
¦æ¨«®É¶¡¹ï§Q¦h¥d¦]¯á³Â«á¤@¹L©Ê¯«¸g¯gª¬µo¥Íªº¼vÅT
(Áé»ï Ķ Á§±iºõ ®Õ¡^
The Influence of Ambulation Time on the Incidence of Transient Neurologic Symptoms After Lidocaine Spinal Anesthesia
Martti Silvanto, Pekka Tarkkila, Marja-Leena Mäkelä, and Per H. Rosenberg
Anesth Analg 2004 98: 642-646.
´î®zÁ_»Ø³s±µ¤¶¾Éªº«H¸¹¶Ç¾É«P¶i¤C¬tîŦb¤j¹«¤¤¼Ï¯«¸g¨t²Îªº³Â¾K®ÄÀ³
(©P¶®¬K Ķ¡@ §õ¤h³q ®Õ¡^
Attenuation of
Gap-Junction-Mediated Signaling Facilitated Anesthetic Effect of Sevoflurane in
the Central Nervous System of Rats
Eiji Masaki, Masahito Kawamura, and Fusao Kato
Anesth Analg 2004 98: 647-652.
¬ü¨Fଥ\¯à©Ê§í¨îN¡Ð¥Ò°òD¡Ð¤Ñ¥V®ò»Ä¨üÅé¦b¤öÃÊßï§Z¥À²ÓM¤¤ªºªí¹F¡G¥ßÅé²§ºcÅé©M¨È³æ¦ìªº®ÄÀ³
(®ï¤å²W¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Functional Inhibition by Methadone of N-Methyl-D-Aspartate Receptors Expressed in Xenopus Oocytes: Stereospecific and Subunit Effects
Robert J. Callahan, John D. Au, Matthias Paul, Canhui Liu, and C. Spencer Yost
Anesth Analg 2004 98: 653-659.
¤v¾J¹ï²§¤T»EÅéG³J¥Õ½è G
i¨È°òªº¼vÅT
(Áé»ï Ķ Á§±iºõ ®Õ¡^
The Effects of Hexanol on G
i
Subunits of Heterotrimeric G Proteins
John Streiff, David O. Warner, Elena Klimtchuk, William J. Perkins, Kristofer Jones, and Keith A. Jones
Anesth Analg 2004 98: 660-7.
¹L®ñ¤Æ¨Èµv»ÄÆQ°§CÂ÷Åé¨ß²Õ´¦]¼Æ¬¡©Ê
¡]¨H ¯E Ķ ¡A§õ¤h³q ®Õ¡^
Peroxynitrite Decreases Rabbit Tissue Factor Activity In Vitro
Vance G. Nielsen and John P. Crow
Anesth Analg 2004 98: 668-671.
·sl¥Íª«N-¥Ò°ò¦h¼{¥»P¦h¼{¥©M¥¬¤ñ¥d¦]§@¬°§½³¡³Â¾KÃįS©Êªº¤ñ¸û
(¦¶½÷¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Local Anesthetic Properties of a Novel Derivative, N-Methyl Doxepin, Versus Doxepin and Bupivacaine
Yukari Sudoh, Elaine Elliott Cahoon, Umberto De Girolami, and Ging Kuo Wang
Anesth Analg 2004 98: 672-676.
¦åºÞÂX±i´£°ª¤j¹«¥¬¤ñ¥d¦]»¤µoÅå³Öªº°ìÈ
(Áé»ï Ķ Á§±iºõ ®Õ¡^
Vasodilation Increases the Threshold for Bupivacaine-Induced Convulsions in Rats
Yutaka Oda, Tomoharu Funao, Katsuaki Tanaka, and Akira Asada
Anesth Analg 2004 98: 677-682.
(°a ªl ¡@Ķ ¡@§õ¤h³q ¡@®Õ¡^
Pretreatment with Thiopental for Prevention of Pain Associated with Propofol Injection
Anil Agarwal, Mohammad F. Ansari, Devendra Gupta, Ravindra Pandey, Mehdi Raza, Prabhat K. Singh, Shiopriye, Sanjay Dhiraj, and Uttam Singh
Anesth Analg 2004 98: 683-686.
§C¯×²§¤þ×ô¨Å¾¯»P¼Ð·Çªº²§¤þ×ô¨Å¾¯ªºÃĮĤñ¸û
(¦¶½÷¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
The Pharmacodynamic Effects of a Lower-Lipid Emulsion of Propofol: A Comparison with the Standard Propofol Emulsion
Dajun Song, Mohamed Hamza, Paul F. White, Kevin Klein, Alejandro Recart, and Omeed Khodaparast
Anesth Analg 2004 98: 687-691.
¤þªyªâ³Â¾K¤¤À³¥Î¸£¹q¹ÏºÊ´ú³Â¾KÃĪ«§@¥ÎªºNarcotrend«ü¼Æ»PÂùÀW«ü¼Æ¤ñ¸û
(©P¾å±ÓĶ Á§±iºõ ®Õ¡^
Narcotrend Index Versus Bispectral Index as Electroencephalogram Measures of Anesthetic Drug Effect During Propofol Anesthesia
Sascha Kreuer, Wolfram Wilhelm, Ulrich Grundmann, Reinhard Larsen, and Jörgen Bruhn
Anesth Analg 2004 98: 692-697.
(¶À¬I°¶ Ķ¡A§õ¤h³q ®Õ¡^
Spectral Analysis of Movement Patterns During Anesthesia (Technical Communication)
Steven L. Jinks, Joseph F. Antognini, and Earl Carstens
Anesth Analg 2004 98: 698-702.
¤j¤â³N«á¯f¤Hµw½¤¥~¦Û±±Âíµh¡]PCEA¡^ªvÀø³N«á¯kµhªº¶O¥Î¤ñ¸û
(Êã¬öµØ¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Cost Drivers in Patient-Controlled Epidural Analgesia for Postoperative Pain Management After Major Surgery
Martin Schuster, André Gottschalk, Marc Freitag, and Thomas Standl
Anesth Analg 2004 98: 708-713.
(©P¾å±Ó
Ķ Á§±iºõ ®Õ¡^
Dextromethorphan-Associated Epidural Patient-Controlled Analgesia Provides Better Pain- and Analgesics-Sparing Effects than Dextromethorphan-Associated Intravenous Patient-Controlled Analgesia After Bone-Malignancy Resection: A Randomized, Placebo-Controlled, Double-Blinded Study
Avi A. Weinbroum, Benjamin Bender, Alexander Nirkin, Shoshana Chazan, Isaac Meller, and Yehuda Kollender
Anesth Analg 2004 98: 714-722.
¤j¹«¤öª¢¯g²Õ´¤¤§t¦³£]¤º°Ø肽ªº§K¬Ì²ÓM´î¤Ö»P§K¬Ì·½©Ê§Ü¶Ë®`§@¥Î¦³Ãö¡G¿é¤J±Ò°Ê²O¤Ú²ÓM¥i°fÂध
(©P¶®¬K Ķ¡@ §õ¤h³q ®Õ¡^
Reduction of ß-Endorphin-Containing Immune Cells in Inflamed Paw Tissue Corresponds with a Reduction in Immune-Derived Antinociception: Reversible by Donor Activated Lymphocytes
Siobhan Hermanussen, MyHong Do, and Peter John Cabot
Anesth Analg 2004 98: 723-729.
¦Û¥Ñ¬¡°Ê¤j¹«Áp¦XÀ³¥Îª½¬y©M¥æ¬y¹q¶i¦æ¸gÆ`¹q¨ë¿Eªº§Ü¶Ë®`§@¥Î
(Êã¬öµØ¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
The Antinociceptive Effect of Transcranial Electrostimulation with Combined Direct and Alternating Current in Freely Moving Rats
Vladimir Nekhendzy, Christo P. Fender, M. Frances Davies, Hendrikus J. M. Lemmens, Michael S. Kim, Donna M. Bouley, and Mervyn Maze
Anesth Analg 2004 98: 730-737.
ÀT¤º©Î¤fªA¥i¼Ö©w¹w¨¾³N«á°sºë§ÙÂ_ºî¦X©º¡X¡X¤@¶µÀH¾÷¡BÂùª¼¹ï·Ó¬ã¨s
(©P¾å±ÓĶ Á§±iºõ ®Õ¡^
Intrathecal and Oral Clonidine as Prophylaxis for Postoperative Alcohol Withdrawal Syndrome: A Randomized Double-Blinded Study
I. Dobrydnjov, K. Axelsson, L. Berggren, J. Samarütel, and B. Holmström
Anesth Analg 2004 98: 738-744.
(»¯³·½¬¡@ Ķ¡@¡@¡@ §õ¤h³q¡@ ®Õ¡^
Decreased Insulin Requirements with Spinal Cord Stimulation in a Patient with Diabetes (Case Report)
Leonardo Kapural, Salim M. Hayek, Michael Stanton-Hicks, and Nagy Mekhail
Anesth Analg 2004 98: 745-746.
(¦¶¼zµ`¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Is Physician Anesthesia Cost-Effective?
J. P. Abenstein, Kirsten Hall Long, Brian P. McGlinch, and Niki M. Dietz
Anesth Analg 2004 98: 750-757.
²§¬tîŹ什¨_©Ê¸£¯Ê¦å¤j¹«¯«¸g¤¸ä¤`ªº¼vÅT
(³°¦°°¶ Ķ Á§±iºõ ®Õ¡^
Effect of Isoflurane on Neuronal Apoptosis in Rats Subjected to Focal Cerebral Ischemia
Masahiko Kawaguchi, John C. Drummond, Daniel J. Cole, Paul J. Kelly, Mark P. Spurlock, and Piyush M. Patel
Anesth Analg 2004 98: 798-805.
¥Îµw½¤¥~®e¶qÂX¥Rªº¯á¡ÐµwÁp¦X³Â¾K¨Ï¾Ü´Áå®c²£«á¹B°Ê«ì´_¸û§Ö¡G¤@¶µ«e¤©Ê¡BÀH¾÷¡BÂùª¼¬ã¨s
(°¨µqµY
Ķ¡@ §õ¤h³q ®Õ¡^
Combined Spinal-Epidural Anesthesia Using Epidural Volume Extension Leads to Faster Motor Recovery After Elective Cesarean Delivery: A Prospective, Randomized, Double-Blind Study
Eileen Lew, Seow-Woon Yeo, and Easaw Thomas
Anesth Analg 2004 98: 810-814.
¹w¨¾©Ê¨Ï¥ÎfµÇ¤W¸¢¯À¥i¨¾¤î帡²£¤â³N¤¤¦]¯á³Â¤Þ°_ªº§C¦åÀ£
(¦¶¼zµ`¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Prophylactic Phenylephrine Infusion for Preventing Hypotension During Spinal Anesthesia for Cesarean Delivery
Warwick D. Ngan Kee, Kim S. Khaw, Floria F. Ng, and Bee B. Lee
Anesth Analg 2004 98: 815-821.
«ùÄò©Ê骶©P©M§¤°©¯«¸gªýº¢¡G¤@¶µX½u¤ù¬ã¨s
(³°¦°°¶ Ķ Á§±iºõ ®Õ¡^
Continuous Parasacral Sciatic Block: A Radiographic Study
Elisabeth Gaertner, Pablo Lascurain, Cyrille Venet, Xavier Maschino, Alina Zamfir, Radu Lupescu, and Admir Hadzic
Anesth Analg 2004 98: 831-834.
§Q¦h¥d¦]ÀR¯ß§½³¡³Â¾K¤¤¥[¤Jdexmedetomidine
(»¯³·½¬¡@ ͧõ¤h³q ®Õ ¡^
Adding Dexmedetomidine to Lidocaine for Intravenous Regional Anesthesia
Dilek Memis, Alparslan Turan, Beyhan Karamanlioglu, Zafer Pamukçu, and Imran Kurt
Anesth Analg 2004 98: 835-840.
¦a¥d¦]¼W¥[¯«¸g¥ÍªøÀ@²ÓM¤º¶tÂ÷¤l
(³¯¼ä¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Intracellular Calcium Increases in Growth Cones Exposed to Tetracaine
Shigeru Saito, Inas A. M. Radwan, Koichi Nishikawa, Hideaki Obata, Tomonori Okamoto, Toshio Kanno, and Fumio Goto
Anesth Analg 2004 98: 841-845.
µu´Áµw½¤¥~ªýº¢¹ï¶¡½è©Ê»H¯Öª¢ªº§¿²GPª«½è¤ô¥ªº¼vÅT
(³°¦°°¶ Ķ Á§±iºõ ®Õ¡^
The Effect of Short-Term Epidural Local Anesthetic Blockade on Urinary Levels of Substance P in Interstitial Cystitis
Andrew Sukiennik, Daniel B. Carr, Iwona Bonney, James E. Marchand, Heinrich Wurm, and Grannum R. Sant
Anesth Analg 2004 98: 846-850.
(ÃCÀÜ Ä¶¡A §õ¤h³q ®Õ¡^
Assessing Residual Neuromuscular Blockade Using Acceleromyography Can Be Deceptive in Postoperative Awake Patients
Christophe Baillard, Sylvie Bourdiau, Philippe Le Toumelin, Farid Ait Kaci, Bruno Riou, Michel Cupa, and C. Marc Samama
Anesth Analg 2004 98: 854-7.
(³¯¼ä¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
The Intubating Laryngeal Mask Airway Facilitates Tracheal Intubation in the Lateral Position
Ryu Komatsu, Osamu Nagata, Daniel I. Sessler, and Makoto Ozaki
Anesth Analg 2004 98: 858-861.
Christophe
Baillard, MD PhD*, Sylvie Bourdiau, MD*, Philippe Le
Toumelin, MD*, Farid Ait Kaci, MD*, Bruno Riou, MD PhD
, Michel Cupa, MD*, and C. Marc Samama,
MD PhD*
*Department
of Anesthesiology and Intensive Care, Avicenne Hospital, Bobigny; and
Department
of Emergency Medicine and Surgery, Pitié-Salpêtrière
Hospital, Pierre et Marie Curie University, Paris, France
Anesth Analg
2004;98:854-7
³N«á²M¿ô¯f¤H¥i¯à¦s¦b©úÅ㪺¯«¸g¦Ù¦×¶Ç¾Éªýº¢´Ý¯d¡C¦b²M¿ôªº¯f¤H¡A¥Ñ©ó²o§è¨ì©æ«üªº¬¡°Ê¥i¯à¼vÅT¥[³t«×»öºÊ´úªºµ²ªG¡C¦b¥»¬ã¨s¤¤¡A§Ú̵û»ù¤F253¨Ò³Â¾K«á´_Ĭ¯f¤H¶i¦æ¥|Ó¦¨¦ê¨ë¿E¡]TOF¡^¤ñȺʴúµ²ªGªº«½Æ©Ê¡C¦b¯f¤H¨ì¹F³Â¾K«áºÊÅ@«Ç§Y¨è¹ï¤Ø¯«¸g¶i¦æTOF¨ë¿E¡A¿Eµoªº¤ÏÀ³³q¹L¥[³t«×»ö¥[¥Hµû©w¡C¹q¬y±j«×¬O30mA¡C¨CÓ¯f¤H¶i¦æ¨â¦¸TOF¨ë¿E¡A¶¡¹j30s¡C¨Ï¥ÎBland-AltmanÀËÅç¡C®Ú¾ÚTOF< 0.9§PÂ_¬O§_¦s¦b¯«¸g¦Ù¦×¶Ç¾Éªýº¢´Ý¯d¡C¨â¦¸ºÊ´úµ²ªGªºÁ{§É¤@P©Ê±Ä¥Î£eÀËÅç¡C«ö¬O§_¦s¦b¯«¸g¦Ù¦×¶Ç¾Éªýº¢´Ý¯d¤ÀªR¡A61¨Ò¡]24%¡F95%¥i«H°Ï¶¡¡A21%-27%¡^¯f¤Hªº¨â¦¸TOFºÊ´úµ²ªG¤£²Å¦X¡C£eÀËÅçªí©ú¨ä²Å¦X«×¤¤µ¥¡]£e= 0.47¡^¡C§ÚÌÃҹꥻ¬ã¨s¤¤¨Ï¥Î¥[³t«×»ö¨Ã«DÁ`¬O·Ç½T¡C¨â¦¸©t¥ßªº¨Ï¥Î¥[³t«×»öºÊ´úªºTOF¤ñȤ£¯à·Ç½T¤Ï¬M³Â¾K«ì´_´Á¯f¤H¯«¸g¦Ù¦×¶Ç¾Éªýº¢ª¬ºA¡C
¡]ÃCÀÜ
Ķ¡A §õ¤h³q ®Õ¡^
Postoperative awake patients may have
significant residual neuromuscular block. In awake patients, the
results of accelerometry are affected by extra movements to which
the thumb may be subject. In this study, we evaluated the
repeatability of train-of-four (TOF) ratio using acceleromyography
in 253 patients recovering from anesthesia. Immediately after
arrival in the postanesthesia care unit, the ulnar nerve was
stimulated with TOF stimulation. The evoked response at the thumb
was measured by the TOF-Watch apparatus. The current intensity was
30 mA. Two TOF stimulations were applied and recorded at 30-s
intervals. A Bland-Altman test was used. The Kappa (
)
test for clinical agreement between the two measurements was also
calculated according to the presence or absence of a residual
neuromuscular blockade, defined as a TOF ratio <0.9. According to
the presence of a residual neuromuscular blockade, the paired TOF
ratios were discordant in 61 patients (24%; 95% confidence interval,
21%¡V27%). The
test
indicated a moderate agreement (k = 0.47). We demonstrated that
accelerometry as used in this study is not always accurate. Two
isolated acceleromyograph TOF ratios are not an accurate representation
of the neuromuscular status of the patient recovering from
anesthesia.
Steven L. Jinks, PhD, Joseph F. Antognini, MD, and Earl Carstens, PhD Department of Anesthesiology and Pain Medicine and the Section of Neurobiology, Physiology and Behavior, University of California, Davis, Davis, California
Anesth
Analg 2004;98:698-702
°Ê§Î¦¡¤¤ªº°ªÀW©M§CÀW³¡¤ÀªºÀWÃФÀªR¦³§U©ó¤F¸ÑÅé°Ê¡]¹ï¶Ë®`©Ê¨ë¿Eªº¤ÏÀ³¡^¬O¦p¦ó³Q³Â¾KÃÄ®ø°£ªº¡C¦]¦¹§Ú̹ï¥H«e¤wµoªíªºÃö©ó¨Ï¥Î0.6¡B0.9©M1.1MACªº²§¬tîÅ©M¬tÖJ³Â¾Kªº¤j¹«ªºÅé°Ê¸ê®Æ¶i¦æ¤FÀWÃФÀªR¡C§Ṵ́O¿ý¤F¥Ñ«á¤ö¨ü¶Ë®`©Ê¾÷±ñ¨ë¿E¤Þ¥Xªº«áªÏµ¥ªø¦¬ÁY¤O¡CÅé°Ê§Î¦¡¸g¹LÀWÃФÀªR¨Ó§P©w¨C¤@ÀW²v³¡¤Àªº¤Oªº´T«×¡C·í¬tÖJ±q0.6¼W¥[¨ì0.9MAC®É¡A¶È¦b³Ì§CÀW³¡¤À¡]<1Hz¡^¤Oªº´T«×¦³°§C¡A»P0.6MAC®É°ªÀW³¡¤À¤O´T´¶¹M¸û§C¦³³¡¤ÀÃö«Y¡C¦b0.6¨ì0.9MACªº²§¬tîŮɡA0¡Ð10Hz½d³ò¤ºªº¤j¦h¼ÆÀW²vªº¤O´T°§C¡C·í²§¬tîÅ©M¬tÖJ§¡¬°1.1MAC®É¡A©M¹w´Áªº¤@¼Ë¡A©Ò¦³ÀW²vªº¤O´T¤j´T¤U°¡C§Ú̱o¥Xµ²½×¡GÀWÃФÀªR¦³§Q©ó´yz©M©w¶q³Â¾KÃĹï¶Ë®`©Ê¨ë¿E¤Þ°_ªº½Æ¦XÅé°Ê§Î¦¡ªº¼vÅT¡C
¡]¶À¬I°¶ Ķ¡A§õ¤h³q ®Õ¡^
It remains unclear how anesthetics
produce immobility, an end-point used in determining anesthetic potency.
Understanding how movement (in response to noxious stimulation) is
ablated by anesthetics could be aided by using spectral analysis of
the high and low frequency components of complex movement patterns.
We therefore applied a spectral analysis to previously published
movement data from rats anesthetized with isoflurane and halothane
at 0.6, 0.9, and 1.1 minimum alveolar concentration (MAC). We
recorded isometric forces of hindlimb movement elicited by noxious
mechanical stimulation of the hindpaw. The movement patterns were
subjected to spectral analysis to determine force amplitude for each
frequency component. When halothane was increased from 0.6 to 0.9
MAC, force amplitude decreased only for the lowest-frequency (<1
Hz) components, in part related to the generally lower high-frequency
forces at 0.6 MAC. Between 0.6 and 0.9 MAC isoflurane amplitude was
reduced for most frequencies in the 0¡V10 Hz range. For both
halothane and isoflurane at 1.1 MAC, as expected, force amplitude
substantially decreased at all frequencies. We conclude that
spectral analysis is useful to describe and quantify the effects of
anesthetics on complex movement patterns resulting from noxious
stimuli applied during anesthesia.
¨àµ£ÁB§Î¤j¤â³N³N«á«ùÄò¸y¦Ù¶¡«Çªýº¢Âíµh¡G¤@¶µ«e¤©ÊCT±½´y¤ÎÁ{§É¸ÕÅç
Continuous Psoas Compartment Blocks After Major Orthopedic Surgery in Children: A Prospective Computed Tomographic Scan and Clinical Studies
C. Dadure, MD*, O. Raux, MD*, P. Gaudard, MD*, M. Sagintaah, MD , R. Troncin, MD*, A. Rochette, MD*, and X. Capdevila, MD PhD*
Departments of *Anesthesia and Critical Care Medicine and¡@ Pediatric Radiology, Lapeyronie University Hospital, Montpellier, France
Address correspondence and reprint requests to Christophe Dadure, MD, Département d¡¦Anesthésie Réanimation A, Hôpital Lapeyronie, 371 Avenue du Doyen G. Giraud, 34295 Montpellier, France.
Anesth Analg 2004 98: 623-628.
ªÑ°©·F©ÎÆb³¡¤â³Nªº¯kµhµ{«×¹ï¨àµ£¨Ó»¡¬Û·íÄY«¡C§ÚÌ¥ÎCT±½´y¤èªk¡A¦P®É¶i¦æÁ{§É«e¤©Ê¸ÕÅç¡A¨Ó½T©w¨àµ£¸y¦Ù¶¡«Çªýº¢ªº·s¼Ð°O¤èªk¡A¨Ãµû»ù¥Î¤@¦¸©Ê¼u©Ê¬¦¶i¦æ«ùÄò¸y¦Ù¶¡«Çªýº¢¡]CPCB¡^ªº¦³®Ä©Ê¡C³q¹L¹w¥ý¹ï20¦W¯f¤H¶i¦æCT±½´y¡Aµo²{¯«¸gÂOªº²`«×»P¯f¤H¦~ÄÖ¬ÛÃö¡ACPCB³Ì¨Î¬ï¨ëÂI¦ì©ó±qL4´Æ¬ð¦Ü¸g¹LóÁ«á¤W´Æªº¯á¬W¥¦æ½u¤§¶¡ªº¶ZÂ÷ªº3/4³B¡CÀH«áªº«e¤©Ê¬ã¨s¨t¦C¤¤¡A¦b±w¨à±µ¨üªÑ°©©MóÁ°©ºI°©¤â³N¤§«e¡Aµ¹¤©CPCB¡A¥Î¥H½w¸Ñ³N«á¯kµh¡C¥þ³Â«á¡A³q¹LCPCB¸mºÞµ¹t²ü¶q1%§Q¦h¥d¦]¡]§t1/200.000µÇ¤W¸¢¯À¡^©M0.5%ù©K¥d¦]²V¦X²G0.5ml/kg¡C¸g¹L³y¼v¾¯½T©w¸mºÞ¦ì¸m«á¡A³s±µ¤@¦¸©Ê¬¦¡]Infusor LV®; Baxter, Paris,
France¡^¡AÃIJG°t¦¨0.2%ªºÃ¹©K¥d¦]¡A®Ú¾ÚÅ髽վã¿éª`³t«×(0.2
mg/ kg/h)¡C³N«á¯kµhµû¤À±Ä¥ÎµøÄ±Ãþ¤ñµû¤À¡]visual analog scale¡^©Î À¦¥®¨à³N«á¯kµhµû¤À¡]Children and Infants Postoperative Pain Score¡^ªk¡Aµû¤À®É¶¡¬°³N«á1, 6, 12, 18, 24, 36¤Î48¤p®É¡A¨Ãµû»ù°l¥[¸É¥RÂíµh±¡ªp¡B°Æ§@¥Î©M¹B°Êªýº¢¡C¤â³N¹Lµ{¤¤©Ò¦³ªýº¢³£¦³®ÄªG¡A³N«áÂíµh¨}¦n¡C¯kµhµû¤À¤¤¦ìÈ1¤p®É®É¬°1¤À¡A 6¤p®É«á¬Ò¬°0¤À¡C³N«á24¤p®É¤º¦³»´·L¹B°Êªýº¢¡A¤§«á«K®ø¥¢¡C¥¼µo²{ÄY«ªº°Æ§@¥Î¡C93%±w¨àªº¤÷¥Àº¡·N¡Cµ²½×¡G¨àµ£¤UªÏªñºÝÁB§Î¤j¤â³N«á¥ÎCPCBÂíµh¡A¬O¤@¶µ«D±`¦³®Äªº§Þ³N¡C»P¤åÄm©Ò´£ªº¶Ç²Î¬ï¨ë¼Ð°Oªk¬Û¤ñ¡A¥»¬ã¨s©Ò´yzªºCT±½´y©w¦ìªk¡A«h§ó¬°«ÈÆ[¡C
¡]©P§Ó°íĶ §õ¤h³q®Õ¡^
Femoral shaft or hip surgeries are very painful for children. We conducted both computed tomographic (CT) and clinical prospective studies to define new landmarks in children and to evaluate the effectiveness of continuous psoas compartment blocks (CPCBs) using disposable elastomeric pumps. In a preliminary CT scan study of 20 patients, the plexus depth was correlated to patient age and the optimal point of puncture for CPCB was three-quarters of the distance from the spinous process of L4 to a line parallel to the spinal column passing through the posterior superior iliac spine. In a subsequent prospective series, a CPCB was administered before surgery to 15 children for pain relief after femoral and hip osteotomies. After general anesthesia, a 0.5 mL/kg bolus of a mixture of 1% lidocaine with epinephrine (1/200.000) and 0.5% ropivacaine was injected through the CPCB catheter. After contrast media assessment of the catheter location, a disposable pump (Infusor LV®; Baxter, Paris, France) with 0.2% ropivacaine was connected and pump flow was adjusted to the patient¡¦s weight (0.2 mg /kg/ h). Postoperative pain was evaluated using a visual analog scale or the Children and Infants Postoperative Pain Score at hour H1, H6, H12, H18, H24, H36, and H48, and in terms of rescue analgesia, adverse events, and motor blocks. All blocks were effective during surgery. Postoperative analgesia was excellent. The median pain scores were 1 for H1 and 0 beginning H6. The motor blockade was minimal before 24 h and absent thereafter. No major adverse event was noted. Parents of 93% of the children were satisfied. We conclude that postoperative analgesia with CPCB is a very effective technique in children after major proximal lower limb orthopedic surgery. The CT scan landmarks described in this study were more medial than the conventional landmarks used in the literature .
´î®zÁ_»Ø³s±µ¤¶¾Éªº«H¸¹¶Ç¾É«P¶i¤C¬tîŦb¤j¹«¤¤¼Ï¯«¸g¨t²Îªº³Â¾K®ÄÀ³
Eiji Masaki, MD PhD*, Masahito Kawamura,
MD
, and Fusao Kato, PhD
Section Editor
Departments of *Anesthesiology,
Pharmacology,
and
Neuroscience,
Jikei University School of Medicine, Tokyo, Japan
Address correspondence and reprint requests to Eiji Masaki, Department of Anesthesiology, Jikei University School of Medicine, 3¡V25¡V8, Nishishinbashi Minato-ku, Tokyo 105¡V8461, Japan.
Anesth
Analg 2004;98:647-652
¶V¨Ó¶V¦hªºÃÒ¾Ú´£¥Ü´î¤Ö¤º¦b¿³¾Ä©Ê©Î¬ðIJ¿³¾Ä©M/©Î¼W±j¬ðIJ§í¨î¬O¥þ¨³Â¾Kª¬ºAªº°ò¦¡C°£¤F¤Æ¾Ç©Ê¬ðIJ¡A¯«¸g¤¸¤§¶¡ÁÙ¯à³q¹LÁ_»Ø³s±µªº¹q½¢Áp¶i¦æ«H¸¹¶Ç¾É¡C§Ṵ́²³]§l¤J³Â¾KÃĪº³Â¾K¾÷¨î¤¤¥]¬A¦b¤¤¼Ï¯«¸g¨t²Î¡]CNS¡^¤¤§í¨î³q¹LÁ_»Ø³s±µªº²ÓM¦Ü²ÓMªº«H¸¹¶Ç¾É¡C¬¡Åé¸ÕÅ礤¦b¸£«Ç¤º¡]ICV¡^©ÎÀT¤º¡]IT¡^µ¹¤©Á_»Ø³s±µ§í¨î¾¯¥Ì¬Ä»Ä¡]CBX¡^«á´ú©w¤C¬tîŪº³Ì§CªÍªw¿@«×¡]MAC¡^¡C¦P®É¦bÂ÷Åé¸ÕÅ礤¥Î½¤¤ù¹X¤èªk°O¿ý¦~»´¤j¹«¸£¾ô¸£¤ùÂÅ´³¯«¸g¤¸¥Ñ©ó¯«¸g¤¸¶¡¹q¶Ç¾É¦Ó²£¥Íªº¦Ûµo½¤¹q¬y¾_Àú¡A¨Ã¥B°O¿ý¤C¬tîŹ惡ºØ¾_Àúªº§@¥Î¡C¸£«Ç¤ºµ¹¤©CBX¡]125©M250ug/Ó¤j¹«¡^¥i¾¯¶q¨Ì¿à¦a´î¤Ö¤C¬tîŪºMAC¡A¦ÓÀT¤ºµ¹¤©CBX¨Ã¤£¯à´î¤ÖMAC¡CÁ{§É¬ÛÃö¿@«×¡]0.1-0.5mM¡^ªº¤C¬tîÅ¥i¾¯¶q¨Ì¿à¦a§í¨î¦Ûµo½¤¹q¬y¾_Àú¡A¤C¬tîŦb0.5mM¿@«×®É¹ï¹q¬y´T«×¤ÎÀW²vªº§í¨î¦³ÅãµÛ©Ê¡C¦¹¬ã¨s´£¥Ü¤C¬tîų¾K§@¥Î¯A¤Î¤¤¼Ï¯«¸g¨t²Î¤ºÁ_»Ø³s±µ¤¶¾Éªº«H¸¹¶Ç¾Éªº§í¨î¡C
¡]©P¶®¬K Ķ¡@ §õ¤h³q ®Õ¡^
Accumulating evidence suggests
that reduction of intrinsic excitability or synaptic excitation and/or an
enhancement of synaptic inhibition underlie the general anesthetic condition.
Besides chemical synapse, neurons could communicate with each other by
electrical coupling via gap-junctions. We hypothesized that inhibition of
cell-to-cell signaling through gap-junction in the central nervous system (CNS)
is involved in the anesthetic mechanism of volatile anesthetics. The minimum
alveolar concentration (MAC) of sevoflurane was measured after the
intracerebroventricular (ICV) or intrathecal (IT) administration of
carbenoxolone (CBX), a gap-junction inhibitor, in vivo. The spontaneous
oscillation in membrane currents of locus coeruleus neurons that results from
electrical coupling between neurons was also recorded from young rat pontine
slices by the patch clamp method, and the effect of sevoflurane on this
oscillation was examined in vitro. The ICV administration of CBX (125 and 250
µg/rat)
significantly reduced the MAC of
sevoflurane dose-dependently, whereas IT injection failed to inhibit the MAC. Sevoflurane
at clinically relevant concentrations (0.1¡V0.5 mM) suppressed the spontaneous
oscillation in membrane current concentration-dependently. These suppressions
were significant at 0.5 mM with both amplitude and frequency. We suggest that
suppression of gap-junction-mediated signaling in the CNS is involved in the
anesthetic-induced immobilization by sevoflurane.
¤j¹«¤öª¢¯g²Õ´¤¤§t¦³£]¤º°Ø肽ªº§K¬Ì²ÓM´î¤Ö»P§K¬Ì·½©Ê§Ü¶Ë®`§@¥Î¦³Ãö¡G¿é¤J±Ò°Ê²O¤Ú²ÓM¥i°fÂध
Siobhan Hermanussen, BSc Hons, MyHong Do, BPharm
Hons, and Peter John Cabot, PhD
The School of Pharmacy, The University of Queensland, Queensland, Australia
Address correspondence and reprint requests to Peter J. Cabot, PhD, The School of Pharmacy, The University of Queensland, 4072, Queensland, Australia.
Anesth
Analg 2004;98:723-729
§K¬Ì¨t²Î¥\¯à§¹¾ã¬O²£¥Í¥~©P§Ü¶Ë®`·P¨ü§@¥Îªº¥²n±ø¥ó¡C¥H«eªº¬ã¨sªí©ú§K¬Ì²ÓM¥i¦bª¢¯g²Õ´¤¤¤Þµo±j®Äªº§Ü¶Ë®`§@¥Î¡C¦b±µ¨ü¹LÀôÌU¯ÀA¡]CsA¡^²£¥Í§K¬Ì§í¨îªº°Êª«¤¤¡A«PµÇ¤W¸¢¥Ö½è¿E¯ÀÄÀ©ñ¦]¼Æ»¤¾Éªº§Ü¶Ë®`§@¥Î¨ü¨ì©úÅ㪺§í¨î¡C§Ú̦¹¶µ¬ã¨sÀËÅç¤F³æ¦¸¾¯¶qCsA¹ïª¢¯g¶Ë®`·P¨üªº§@¥Î¡C±µ¨üCsAªº¤j¹«¸û¨S¦³²£¥Í§K¬Ì§í¨îªº¤j¹«¶Ë®`©Ê§@¥Î©úÅã¼W¥[¡A¦P®É°j°é¤¤©M²Õ´¤¤²O¤Ú²ÓM´î¤Ö¡C¦¹¥~¡ACsA§í¨î¤j¹««PµÇ¤W¸¢¥Ö½è¿E¯ÀÄÀ©ñ¦]¼Æ»¤¾Éªº§K¬Ì·½©Ê§Ü¶Ë®`§@¥Î¡AÀR¯ßª`®g¥~·½©Ê¸g¤M¨§¯ÀA±Ò°Êªº²O¤Ú²ÓM¡]1.0¡Ð7.0x106²ÓM/0.1²@¤É¡^¥i°fÂহºØ®ÄÀ³¡A¥B¨ã¦³¾¯¶q¨Ì¿à©Ê¡Cµ²½×¡G¸Óµo²{´£¨Ñ¶i¤@¨BÃÒ¾ÚÃÒ©ú§tªü¤ùªº§K¬Ì²ÓM¬O¥~©PÂíµhªº¥²n±ø¥ó¡C³o¨Çµo²{ÁÙªí©úª¢©Ê¯kµhªº±±¨î«Ü¤j³¡¤À¨Ì¿à©ó¥\¯à¨}¦nªº§K¬Ì¨t²Î¡C
¡]©P¶®¬K
Ķ¡@ §õ¤h³q ®Õ¡^
The functional integrity of the immune system is essential for peripheral antinociception. Previous studies have demonstrated that immune cells elicit potent antinociception in inflamed tissues and that corticotropin-releasing factor-induced antinociception is significantly inhibited in animals that have undergone cyclosporin A (CsA)-induced immunosuppression. In this study, we examined the effect of a single bolus of CsA on inflammatory nociception. CsA-treated rats had substantially increased nociception compared with nonimmunosuppressed rats, consistent with a reduction in circulating and infiltrating lymphocytes. Furthermore, CsA-treated rats had inhibition of corticotropin-releasing factor-induced immune-derived antinociception, which was dose-dependently reversed by IV injection of concanavalin A-activated donor lymphocytes (1.0¡V7.0 x 106 cells/0.1 mL). In conclusion, our findings provided further evidence that opioid-containing immune cells are essential for peripheral analgesia. It is evident from these findings that control of inflammatory pain relies heavily on a functioning immune system.
¥Îµw½¤¥~®e¶qÂX¥Rªº¯á¡ÐµwÁp¦X³Â¾K¨Ï¾Ü´Áå®c²£«á¹B°Ê«ì´_¸û§Ö¡G¤@¶µ«e¤©Ê¡BÀH¾÷¡BÂùª¼¬ã¨s
Combined Spinal-Epidural
Anesthesia Using Epidural Volume Extension Leads to Faster Motor Recovery After
Elective Cesarean Delivery: A Prospective, Randomized, Double-Blind Study
Eileen Lew, MBBS MMed, Seow-Woon Yeo, MBBS MMed, FAMS, and Easaw Thomas, MBBS FANZCA, FAMS Section Editor
From the Department of Anaesthesia (Obstetrics and Gynaecology), KK Women¡¦s and Children¡¦s Hospital, Singapore
Anesth Analg 2004;98:810-814
¦b¯á³Â¡Ðµw½¤¥~ªýº¢Áp¦X³Â¾K¡]CSE¡^®É¡A±Ä¥Îµw½¤¥~®e¶qÂX¥R¡]EVE¡^§Þ³N¬O³q¹Lµw½¤¥~µÄª`®g¥Í²zÆQ¤ô¨Ï¤p¾¯¶qÀT¤ºªýº¢¼W±jªº¤èªk¡C¦b¦¹¶µ«e¤©Ê¡BÀH¾÷¡BÂùª¼ªº¬ã¨s¤¤¡A§Ṳ́ñ¸û¤FEVE¤èªk»P³æ¦¸ª`®g¯á³Âªº·Pı©M¹B°Êªýº¢¯S©Ê¤Î¦å¬y°Ê¤O¾Çéw©Ê¡C62¨Ò¶i¦æ¾Ü´Áå®c²£ªºÁ{²£°ü¡]¦U²Õn¡×31¡^µ¹¤©«¤ñ«0.5%¥¬¤ñ¥d¦]9mg¡Ïªâ¤Ó¥§10 µg¯á³Â¡F©ÎCES§Y«¤ñ«0.5%¥¬¤ñ¥d¦]5mg¡Ïªâ¤Ó¥§10
µg¯á³Â«á5 min³q¹Lµw½¤¥~¾ÉºÞª`®g0.9%ÆQ¤ô6.0 ml¡C¨C¹j2.5 min°O¿ý¦U²Õªº³Ì§C¦¬ÁY¦åÀ£¡]SBP¡^¡B°w¨ëµLµhªº·Pıªýº¢¥±©M§ï¨}Bromageµû¤À¡C¤ñ¸û¨â²ÕªºµøÄ±Ãþ¤ñ¯kµhµû¤À¡]VAS¡^¡B³Ì°ª·Pıªýº¢¥±¡B³Ì°ª§ï¨}Bromage¹B°Êµû¤À¡B·Pıªýº¢®ø°h¨ì²Ä10¯Ý¬q¯áÅè¥Ö°Ï¡]T10¡^©Ò»Ýªº®É¶¡©M¹B°Êªýº¢ªº«ì´_¡C¨â²Õ¯f¤Hªº¤@¯ë¸ê®Æ¡BVASµû¤À¡B³Ì°ª·Pıªýº¢¥±¡B·Pıªýº¢®ø°h¨ìT10©Ò»Ýªº®É¶¡¤Î°O¿ýªº³Ì§CSBP§¡¬Û¦ü¡CEVE²Õªº¯f¤HÅã¥Ü¹B°Ê«ì´_¨ì§ï¨}Bromage 0¤ô¥ªº®É¶¡ÅãµÛ¸û§Ö(73 ¡Ó 33 min vs. 136 ¡Ó 32 min, P < 0.05)¡C´£¥Ü¡G»P¶Ç²Îªº³æ¦¸ª`®g¯á³Â¬Û¤ñ¡A¤p¾¯¶q¯á´Õªýº¢ªºµw½¤¥~®e¶qÂX¥R¥u»Ý55%ªº¥¬¤ñ¥d¦]¾¯¶q´N¯à´£¨Ñº¡·Nªºå®c²£³Â¾K¡A¥B¤UªÏ¹B°Ê«ì´_¸û§Ö¡C
¡]°¨µqµY Ķ¡@ §õ¤h³q ®Õ¡^
Epidural volume extension (EVE) via a combined spinal-epidural (CSE) technique is the enhancement of a small-dose intrathecal block by epidural saline boluses. In this prospective, randomized, double-blind study, we compared the EVE technique with single-shot spinal anesthesia with respect to its sensory and motor block profile and hemodynamic stability. Sixty-two parturients (n = 31 in each group) undergoing elective cesarean deliveries were administered either spinal anesthesia with hyperbaric 0.5% bupivacaine 9 mg and fentanyl 10 µg or CSE comprising intrathecal hyperbaric 0.5% bupivacaine 5 mg with fentanyl 10 µg, followed by 0.9% saline 6.0 mL through the epidural catheter 5 min thereafter. In each group, the lowest systolic blood pressure (SBP), sensory block level to loss of pain from pinprick, and modified Bromage scores were recorded at 2.5-min intervals. The visual analog pain score (VAS), peak sensory block height, highest modified Bromage motor score, time for sensory regression to the tenth thoracic dermatome (T10), and motor block recovery were compared between groups. Both groups were comparable in demographic data, VAS scores, peak sensory block height, time for sensory regression to T10, and lowest SBP recorded. Patients in the EVE group demonstrated significantly faster motor recovery to modified Bromage 0 (73 ¡Ó 33 min versus 136 ¡Ó 32 min, P < 0.05).
°ª®ñ¼W±j²§¤þ×ôµÎ±i«aª¬°Ê¯ßªº§@¥Î
Amplification by Hyperoxia of Coronary Vasodilation
Induced by Propofol
Alexandre Ouattara, MD*,
, Gilles Boccara, MD PhD*,
, Patrick Lecomte, MD*,
, Rachid Souktani, PhD*,
, Philippe Le Cosquer, MD*,
, Stéphane Mouren, MD PhD*,
, Pierre Coriat, MD*,
, and Bruno Riou, MD PhD*,
*Laboratory of
Anesthesiology, Université Pierre et Marie Curie, Paris;
Department
of Anesthesiology and Critical Care, Centre Hospitalier Universitaire
Pitié-Salpêtrière, Assistance Publique-Hôpitaux de
Paris;
Department
of Emergency Medicine and Surgery, Centre Hospitalier Universitaire
Pitié-Salpêtrière, Paris, France
Anesth Analg
2004;98:595-603
§Ú̦bÂ÷Åé¡B¬õ²ÓMÄéª`ªº¨ß¤ß¼Ò«¬¤¤ÀËÅç¤F³o¼Ë¤@Ó°²³]¡G¦bµL°ª®ñ(PaO2 = 137 ¡Ó 16 mm Hg, n = 12)©M¦³°ª®ñ(PaO2
= 541 ¡Ó 138 mm Hg, n = 12)ªº±¡ªp¤U¡A²§¤þ×ô(10¡V300 µM)¹ïÂ÷Åé«aª¬°Ê¯ß©M¤ß¦Ù§@¥ÎÅãµÛ¤£¦P¡C°ª®ñ»¤¾É«aª¬°Ê¯ßÅãµÛ¦¬ÁY(-13% ¡Ó 7%)¡C°ª®ñ®É²§¤þ×ôµÎ±i«aª¬°Ê¯ßªº§@¥Î¼W±j¡C¦]¬°¤w¦³³ø¾É®ñ¤ÀÀ£°ª³q¹LÃö³¬ATP±Ó·Pªº¹[³q¹D¨Ï«aª¬°Ê¯ß¦¬ÁY¡A§Ú̬ã¨s¤F¦bµL°ª®ñ©M¦³°ª®ñ±¡ªp¤U¥Î®æ¦C¥»脲¡]glibenclamide ¡^0.6 µM©Mcromakalim 0.5 µM¹w³B²zªº¥t¥~¨â²Õ¡]¦U²Õn=6¡^¤ßŦ¤¤²§¤þ×ôªº§@¥Î¡C®æ¦C¥»脲¹w³B²z¨Ï«aª¬°Ê¯ß¦¬ÁY(-16%
¡Ó 7%)¡A¦ý¤£¼vÅT²§¤þ×ôªº«aª¬°Ê¯ßµÎ±i§@¥Î¡CCromakalim¹w³B²z¥h°£¤F°ª®ñ®É²§¤þ×ô«aª¬°Ê¯ßµÎ±i§@¥Îªº¼W±j¡C¦bµL°ª®ñ©M¦³°ª®ñ±¡ªp¤U¡A²§¤þ×ô¿@«×>100
µM§¡ÅãµÛ°§C¤ß¦Ù©Ê¯à¡C§Ú̱o¥Xµ²½×¡G°ª®ñ¼W±j²§¤þ×ôµÎ±i«aª¬°Ê¯ßªº§@¥Î¡C¦¹²{¶H¤£¯à¥Î®æ¦C¥»脲¤Þ°_ªº«aª¬°Ê¯ß¦¬ÁYªº²{¶H¸ÑÄÀ¡C¦ý¬O¡ACromakalim¤ßŦ¹w³B²z¥h°£¤F°ª®ñ®É²§¤þ×ô«aª¬°Ê¯ßµÎ±i§@¥Îªº¼W±j¡C°ª®ñ¤£¼vÅT²§¤þ×ôªº¤ß¦Ù§@¥Î¡C
¡]°¨µqµY Ķ¡@ §õ¤h³q ®Õ¡^
¡@We tested the hypothesis that in vitro coronary and myocardial effects of propofol (10¡V300 µM) should be significantly modified in an isolated and erythrocyte-perfused rabbit heart model in the absence (PaO2 = 137 ¡Ó 16 mm Hg, n = 12) or in the presence (PaO2 = 541 ¡Ó 138 mm Hg, n = 12) of hyperoxia. The induction of hyperoxia provoked a significant coronary vasoconstriction (-13% ¡Ó 7%). Propofol induced increased coronary vasodilation in the presence of hyperoxia. Because high oxygen tension has been reported to induce a coronary vasoconstriction mediated by the closure of adenosine triphosphate-sensitive potassium channels, we studied the effects of propofol in 2 additional groups of hearts (n = 6 in each group) pretreated by glibenclamide (0.6 µM) and cromakalim (0.5 µM) in the absence and presence of hyperoxia, respectively. The pretreatment by glibenclamide induced a coronary vasoconstriction (-16% ¡Ó 7%) which did not affect propofol coronary vasodilation. The pretreatment by cromakalim abolished the amplification of propofol coronary vasodilation in the presence of hyperoxia. Propofol induced a significant decrease in myocardial performance for a concentration >100 µM both in the absence and presence of hyperoxia. We conclude that propofol coronary vasodilation is amplified in the presence of hyperoxia. This phenomenon is not explained by the previous coronary vasoconstriction induced by glibenclamide. However, the pretreatment of hearts by cromakalim abolished the amplification of propofol coronary vasodilation in the presence of hyperoxia. The myocardial effects of propofol were not affected by the presence of hyperoxia.
³N«eªA¥Îªü´µ¤ÇªL¯f¤H¹w¨¾©ÊÀ³¥Î¥h®ò¥[À£¯À¨Ã¯à¤£´î¤Ö«a¯ß¤â³N«á¥X¦å¶qProphylactic
Treatment with Desmopressin Does Not Reduce Postoperative Bleeding After
Coronary Surgery in Patients Treated with Aspirin Before Surgery
Hilde Pleym, MD*,
Roar Stenseth, MD PhD*, Alexander Wahba, MD PhD
, Lise Bjella, MD*, Arve Tromsdal, MD
, Asbjørn Karevold, MD
, and Ola Dale, MD PhD*,
Departments of *Anesthesiology and
Cardiothoracic
Surgery, St. Olav University Hospital; and
Department
of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University
of Science and Technology, Trondheim, Norway
¤H¤u¦X¦¨ªº¦åºÞ¥[À£¯À¡Ð¥h®ò¥[À£¯À¨ã¦³¤î¦å¯S©Ê¡A¥i¯à´î¤Ö«aª¬°Ê¯ß·f¾ô³N¡]CABG¡^«á¥X¦å¶q¡C¤@¶µÃö©óªñ´ÁªA¥Îªü´µ¤ÇªL¦b¤ßŦ¤â³N¤¤¹ï¦å¤pªO¥\¯à¼vÅTªº¬ã¨sÅã¥Ü¡A³N«e2¤é¤ºªA¥Îªü´µ¤ÇªL¹ï¦å¤pªO¥\¯à¦³¸û¤jªº·l®`¡C§Ú̦bªA¥Îªü´µ¤ÇªL75©Î160
mg¦Ü³N«e¤@¤Ñ¦Ó¦æCABG³Nªº¯f¤H¤¤µû¦ô¥h®ò¥[À£¯À¹ï³N«á¥X¦å¶qªº¼vÅT¡C¥»¬ã¨s¬°«e¤©Ê¡BÀH¾÷¡BÂùª¼¡B¦w¼¢¾¯¹ï·Ó¡B¥¦æ¤À²Õ¸ÕÅç¡C100¨Ò¯f¤H¤À¦¨¤G²Õ¡C¤@²Õ¦b²¸»Ä³½ºë³J¥Õ«ú§Ü¨x¯À«áµ¹¤©¥h®ò¥[À£¯À0.3 µg/kg¡A¥t¤@²Õ«hµ¹¤©¦w¼¢¾¯¡]0.9%¥Í²zÆQ¤ô¡^¡C°O¿ý³N«á16¤p®É¤º¥X¦å¶q¡C¥h®ò¥[À£¯À²Õ¥§¡¥X¦å¶q¡]¼Ð·Ç®t¡^¬°606¡]237¡^mL¡A¹ï·Ó²Õ¬°601
(301) mL(P = 0.93)¡AµL©úÅã®t²§¡]95%¥i«H°Ï¶¡¬°107¡X117
mL¡^¡Cµ²½×¡G¥h®ò¥[À£¯À¨Ã¤£´î¤ÖªA¥Îªü´µ¤ÇªL¦Ü³N«e¤@¤Ñ¯f¤HCABG³N«á¥X¦å¶q¡C
¡]¤ý¥ß¤¤Ä¶¡@ §õ¤h³q®Õ¡^
The synthetic vasopressin analog desmopressin has hemostatic
properties and may reduce postoperative bleeding after coronary artery
bypass grafting (CABG). A study on the effects of recent aspirin
ingestion on platelet function in cardiac surgery showed a greater
impairment of platelet function in patients treated with aspirin
<2 days before the operation. We evaluated the effects of
desmopressin on postoperative bleeding in CABG patients who were
treated with aspirin 75 or 160 mg until the day before surgery. The
study was a prospective, randomized, double-blinded, placebo-controlled,
parallel group trial. One-hundred patients were included and divided
into two groups. One group received desmopressin 0.3 µg/kg and
the other received placebo (0.9% NaCl) after the neutralization of
heparin with protamine sulfate. Postoperative blood loss was
recorded for 16 h. The mean (SD) bleeding was 606 (237) mL in the
desmopressin group and 601 (301) mL in the placebo group (P = 0.93), representing no significant
difference (95% confidence interval, -107 to 117 mL). We conclude
that desmopressin does not reduce postoperative bleeding in CABG
patients treated with aspirin until the day before surgery.
¹L®ñ¤Æ¨Èµv»ÄÆQ°§CÂ÷Åé¨ß²Õ´¦]¼Æ¬¡©Ê
Peroxynitrite Decreases Rabbit Tissue Factor Activity In
Vitro
Vance G,Nielsen,MD,*and John P.Crow,PhD*.
Department of *Anesthesiology . Pharmacology/Toxicology, Biochemistry and Molecular Genetics,The Center for Free Radical Biology, The University of Alabama at Birmingham
Anesth Analg 2004;98:668-671.
²Õ´¦]¼Æ¬O¾÷Å餺¤Þ°_¥Í²z©Ê¾®¶°¤ÏÀ³ªº¤@ºØ«nª«½è¡C¹L®ñ¤Æ¨Èµv»ÄÆQ¡]OONO-¡^¤À¤l¯à²£¥Í®ñ¤Æ´á(NO)©M¶W®ñ¤Æª«(O2-)¡A¥i¥H¦bÅé¥~°§C¤H²Õ´¦]¼Æªº¬¡©Ê¡C¦b¨x¤p¸z§½³¡¯Ê¦å¦AÄéª`©Ò¾ÉPªº¾®¦å¯f¤¤¡A¤]¯A¤Î¨ì¹L®ñ¤Æ¨Èµv»ÄÆQªº§Î¦¨¡C¦Ó¥B¡A¨ß¨x¤p¸z§½³¡¯Ê¦å¦AÄéª`«á°j°é¤¤ªº²Õ´¦]¼Æ¬¡©ÊÅãµÛ°§C¡C§Ú̱À´ú¨ß²Õ´¦]¼Æ¼ÉÅS¦b¹L®ñ¤Æ¨Èµv»ÄÆQ«á¥i¨Ï¨ä¬¡©Ê°§C¡C¹L®ñ¤Æ¨Èµv»ÄÆQ¥i¥H¥ÑSIN¡Ð1¡]3-morpholinosydnonimine¡^²£¥Í¡A SIN¡Ð1¥i¥H§Î¦¨®ñ¤Æ´á©M¶W®ñ¤Æª«¡C¨ß¸£²Õ´¦]¼Æ¤À§O¦b¤U¦C·»²G¤¤¥H37¢J¹å¨|90¤ÀÄÁ(¨C²Õn=8 )¡G①0mM SIN-1, ②5mM SIN-1, ③ 5mM SIN-1 ©M 2000 U/mL¤H«²Õ¶W®ñ¤Æª«ª[¤Æ酶¡]hSOD1¡^¡A④2000 U/mL¤H«²Õ¶W®ñ¤Æª«ª[¤Æ酶¡]hSOD1¡^¡CµM«á±N³o¨Ç²Õ´¦]¼Æ¼Ë¥»¥[¤J¤H¦å¼ß¤¤¡A¥Î¦å®ê¼u©Ê´y°O¹Ï´ú©w¦å¾®¶ô§Î¦¨°Ê¤O¾Ç¡Aµû©w²Õ´¦]¼Æªº¬¡©Ê¡C²Õ´¦]¼Æ¼ÉÅS¦bSIN¡Ð1¤¤¨ä¬¡©Ê°§C¤F48¢H¡C»P¨ä¥L¤T²Õ¤ñ¸û¦³ÅãµÛ©Ê®t²§(P<0.01)¡C¨ä¥L´X²Õ¶¡µ²ªGµLÅãµÛ©Ê®t²§¡C§Ú̪ºµ²½×¬O¡A¨ß²Õ´¦]¼Æ³Q¹L®ñ¤Æ¨Èµv»ÄÆQ©Ò§í¨î¡A´¦¥Ü¹L®ñ¤Æ¨Èµv»ÄÆQ¦b¨xŦ¤p¸z§½³¡¯Ê¦å¦AÄéª`©Ò¾ÉPªº¾®¦å¯f©Ò°_¨ìªº§@¥Î¤´»ÝÄ~Äò¬ã¨s¡C
¡]¨H ¯E Ķ ¡A§õ¤h³q ®Õ¡^
Tissue factor (TF) is a primary initiator of physiological coagulation in vivo.Peroxynitrite (OONO-),a molecule formed nitric oxide (NO) and superoxide (O2-),decreases human TF activity in vitro. Coagulopathy has been associated with hepatoenteric ischemia-reperfusion¡@ known to involve formation of OONO-. Further , circulating TF activity decreases in rabbits after hepatoenteric ischemia-reperfusion.We hypothesized that exposure of rabbit TF to OONO- would result in a decrease in activity. OONO- generation was performed with 3-morpholinosydnonimine(SIN-1),a molecule that produces both nitric oxide and superoxide .Rabbit brain TF was incubated at 37C for 90 min with 1)0mM SIN-1, 2)5mM SIN-1, 3) 5mM SIN-1 and 2000 U/mL recombinant human superoxide¡@ dismutase (hSOD1),or 4)2000 U/mL hSOD1(n=8 per condition ) .TF activity was assessed by addition of TF samples to human plasma and measuring clot formation kinetics with a thrombelastograph. TF exposure to SIN-1 resulted in a 48%decrease in activity that was significantly different from the other three conditions (P<0.01). There were no significantly differences between the other conditions .We conclude that rabbit TF is inhibited by OONO-,and further investigation to determine the role of OONO- in coagulopathies associated with hepatoenteric ischemia-reperfusion is warranted.
Anil Agarwal, MD,
Mohammad F. Ansari, MD, Devendra Gupta, MD, Ravindra Pandey, MD, Mehdi Raza,
MD, Prabhat K. Singh, MD, Shiopriye, MBBS, Sanjay Dhiraj, MD, and Uttam Singh,
PhD*
Departments of Anesthesia and *Biostatistics, Sanjay Gandhi
Post Graduate Institute of Medical Sciences, Lucknow, India
Anesth Analg 2004;98:683-686
¤þªy×ôª`®gµhªºµo¥Í²v¬ù¬°28%¡V90%¡A¬°´î¤Ö¯kµh©Ò¸Õ¥Îªº¤èªk«Ü¦h¡A®ÄªG¦U²§¡C§Ṳ́ñ¸û¤FªýÂ_ÀR¯ß«á¡A¹w¥ýª`®g²¸¼Q§´¶u0.25
mg/kg¡A0.5 mg/kg©Î§Q¦h¥d¦]40 mg¹w¨¾¤þªy×ôª`®gµhªº®ÄªG¡C124¨Ò¦¨¦~±wªÌ¡AASA I¡VII¯Å¡A¦æ¾Ü´Á¤â³N¡AÀH¾÷¤À¬°¥|²Õ¡A¨C²Õ31¤H¡C²ÕI¹wª`¥Í²zÆQ¤ô¡A²ÕII 2%§Q¦h¥d¦]40 mg¡A²ÕIII²¸¼Q§´¶u0.25 mg/kg¡A²ÕIV²¸¼Q§´¶u0.5 mg/kg¡C¦U¹wª`Ãħ¡µ}ÄÀ¦Ü2 mL¡A¦P®É¤âªkªýÂ_ÀR¯ß¦^¬y1¤ÀÄÁ¡CÀR¯ß¶}©ñ«áª`®g¤þªy×ô¡C¯kµhµû¤À±Ä¥Î¥|¤Àªk¡Aª`®g®ÉµLµh¬°0¤À¡A»´·Lµh¬°1¤À¡A¤¤«×µh¬°2¤À¡A««×µh¬°3¤À¡C¥Í²zÆQ¤ô²Õ 24¨Ò±wªÌ¡]77%¡^¥D¶Dª`®gµh¡A²ÕII¡B²ÕIII¡B²ÕIV¤À§O¬°12
¨Ò¡]39%¡^¡B10¨Ò ¡]32%¡^©M 1 ¨Ò¡]3%¡^¡]P < 0.05¡^¡C²¸¼Q§´¶u0.5 mg/kg¹w¨¾¤þªy×ôª`®gµh³Ì¦³®Ä¡C§Ú̱ÀÂ˱`³W¹wª`²¸¼Q§´¶u0.5 mg/kg¡A¦P®É¤âªkªýÂ_ÀR¯ß¦^¬y1¤ÀÄÁ¡A¨Ó¹w¨¾¤þªy×ôª`®gµh¡C
¡]°a ªl¡@ Ķ¡@ §õ¤h³q¡@ ®Õ¡^
Propofol causes pain on IV injection in 28%¡V90% of patients.
A number of techniques have been tried to minimize propofol-induced pain,
with variable results. We compared the efficacy of pretreatment with
thiopental 0.25 mg/kg and 0.5 mg/kg and lidocaine 40 mg after venous
occlusion for prevention of propofol-induced pain. One-hundred-twenty-four
adult patients, ASA physical status I¡VII, undergoing elective
surgery were randomly assigned into 4 groups of 31 each. Group I
received normal saline, group II received lidocaine 2% (40 mg), and
groups III and IV received thiopental 0.25 mg/kg and 0.5 mg/kg,
respectively. All pretreatment drugs were made in 2 mL and were
accompanied by manual venous occlusion for 1 min. Propofol was
administered after release of venous occlusion. Pain was assessed
with a four-point scale: 0 = no pain, 1 = mild pain, 2 = moderate
pain, and 3 = severe pain at the time of propofol injection.
Twenty-four patients (77%) complained of pain in the group
pretreated with normal saline as compared with 12 (39%), 10 (32%),
and 1 (3%) in the groups pretreated with lidocaine 40 mg, thiopental
0.25 mg/kg, and thiopental 0.5 mg/kg, respectively (P < 0.05). Thiopental 0.5 mg/kg was the
most effective treatment. We therefore suggest routine pretreatment
with thiopental 0.5 mg/kg along with venous occlusion for 1 min for
prevention of pain associated with propofol injection.
§Q¦h¥d¦]ÀR¯ß§½³¡³Â¾K¤¤¥[¤Jdexmedetomidine
Dilek Memi
, MD*, Alparslan Turan, MD*,
Beyhan Karamanl
o
lu, MD*, Zafer Pamukçu, MD*,
and Imran Kurt, MD
Departments of *Anaesthesiology and
Biostatistics,
Trakya University Medical Faculty, Edirne, Turkey
Anesth Analg 2004;98:835-840
Dexmedetomidine¹ï
-2µÇ¤W¸¢¯À¯à¨üÅ骺¿ï¾Ü©Ê¬O¥i¼Ö©wªº8¿¦h¡C¨ã¦³Âíµh®ÄÀ³¨Ã¯à´î¤Ö¹F90%ªº³Â¾KÃĥζq¡C¥»¹êÅçµû¦ô§Q¦h¥d¦]ÀR¯ß§½³¡³Â¾K¥[¤JDexmedetomidineªº®Ä¯à¡C¹êÅçÆ[¹î¹B°Ê©M·Pıªýº¢ªº°_®Ä©Mºû«ù®É¶¡¡A³Â¾K½è¶q¡A³N¤¤©M³N«á¦å¬y°Ê¤O¾Ç°Ñ¼Æ¥H¤Î³N¤¤©M³N«á¯kµh©MÂíÀR±¡ªp¡C30¨Ò¤â³¡¤â³N±wªÌÀH¾÷¤À¬°2²Õ¦æÀR¯ß§½³¡³Â¾K¡C¹ï·Ó²Õ¬°0.5%§Q¦h¥d¦]40 mL¥[1 mL µ¥±iÆQ¤ô
( L²Õ, n = 15). ¹êÅç²Õ¬° 0.5%§Q¦h¥d¦]40
mL¥[0.5 µg/kg dexmedetomidine (LD²Õ,
n = 15)¡C°O¿ý·Pı©M¹B°Êªýº¢°_®Ä©M«ì´_®É¶¡¤Î³Â¾K½è¶q¡CÀ³¥Î¤î¦å±a«e©MÀ³¥Î«á¡@ 5, 10, 15, 20, ©M40
min°O¿ý¦å¬y°Ê¤O¾Ç°Ñ¼Æ¡B¤î¦å±a¯kµh¡BÂíÀR©MÂíµhÃĪ«¨Ï¥Î±¡ªp¡CªQ¤î¦å±a«á30 min, ©M2, 4, 6, 12, 24 h°O¿ý¦å¬y°Ê¤O¾Ç°Ñ¼Æ¡B¯kµh©MÂíÀR¼ÆÈ¡Bn¨D²Ä¤@¦¸ÂíµhÃĪº®É¶¡¡BÂíµhÃĪº¨Ï¥Î±¡ªp¤Î¤£¨}¤ÏÀ³¡C¦bLD²Õ·Pı©M¹B°Êªýº¢°_®Ä®É¶¡ÁYµu¡A·Pı©M¹B°Ê«ì´_®É¶¡©µªø¡A¹ï¤î¦å±aªº@¨ü®É¶¡©µªø¡A³Â¾K½è¶q´£°ª¡C³N¤¤©MªQ¤î¦å±a«á30 min,
©M 2, 4, and 6 h¡ALD²ÕªºVASµû¤ÀÅãµÛ§C©óL²Õ¡CLD²Õ³N¤¤©M³N«áÂíµhÃĪºn¨D¶q©úÅã§C©óL²Õ¡C²Ä¤@¦¸n¨DÂíµhÃĪº®É¶¡LD²ÕÅãµÛ©µ¿ð¡Cµ²½×¡G¦æIVRA®É¦b§Q¦h¥d¦]¤¤¥[¤Jdexmedetomidine¯à´£°ª³Â¾K½è¶q©M³N¤¤Âíµh®ÄªG«o¤£·|¤Þ°_¤£¨}¤ÏÀ³
¡]»¯³·½¬¡@ ͧõ¤h³q ®Õ ¡^
¡@Dexmedetomidine is
approximately 8 times more selective toward the
-2-adrenoceptors
than clonidine. It decreases anesthetic requirements by up to 90%
and induces analgesia in patients. We designed this study to evaluate
the effect of dexmedetomidine when added to lidocaine in IV regional
anesthesia (IVRA). We investigated onset and duration of sensory and
motor blocks, the quality of the anesthesia,
intraoperative-postoperative hemodynamic variables, and
intraoperative-postoperative pain and sedation. Thirty patients
undergoing hand surgery were randomly assigned to 2 groups to
receive IVRA They received 40 mL of 0.5% lidocaine and either 1 mL
of isotonic saline (group L, n
= 15) or 0.5 µg/kg dexmedetomidine (group LD, n = 15). Sensory and motor block onset and
recovery times and anesthesia quality were noted. Before and after
the tourniquet application at 5, 10, 15, 20, and 40 min, hemodynamic
variables, tourniquet pain and sedation, and analgesic use were
recorded. After the tourniquet deflation, at 30 min, and 2, 4, 6,
12, and 24 h, hemodynamic variables, pain and sedation values, time
to first analgesic requirement, analgesic use, and side effects were
noted. Shortened sensory and motor block onset times, prolonged sensory
and motor block recovery times, prolonged tolerance for the
tourniquet, and improved quality of anesthesia were found in group
LD. Visual analog scale scores were significantly less in group LD
in the intraoperative period and 30 min, and 2, 4, and 6 h after
tourniquet release. Intra-postoperative analgesic requirements were
significantly less in group LD. Time to first analgesic requirements
was significantly longer in group LD in the postoperative period. We
conclude that the addition of 0.5 µg/kg dexmedetomidine to
lidocaine for IVRA improves quality of anesthesia and perioperative
analgesia without causing side effects.
¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@
Leonardo Kapural,
MD PhD, Salim M. Hayek, MD PhD, Michael Stanton-Hicks, MB BS, and Nagy Mekhail,
MD PhD
Department of Pain Management, The Cleveland Clinic
Foundation, Cleveland, Ohio
Address correspondence and reprint requests to Leonardo
Kapural, MD, PhD, Pain Management Center, The Cleveland Clinic Foundation, 9500
Euclid Ave. Desk C25, Cleveland, OH 44195.
Anesth Analg 2004;98:745-746
§Ṳ́¶²Ð¤@¨ÒII«¬¿}§¿¯f±wªÌ¦b¦æ¯áÅè¨ë¿E«á¦å¿}±±¨î±o¨ìÅãµÛ§ïµ½©M©úÅã°§C¯Ø®q¯Àªº»Ýn¶q¡C§Ú̬۫H¯áÅè¨ë¿E§ó¦³¯q©óªø´Á¯kµhªº¿}§¿¯f¤H¡C
¡]»¯³·½¬¡@ Ķ¡@¡@¡@ §õ¤h³q¡@ ®Õ¡^
We describe a case of type-2 diabetes mellitus with
significant improvement in blood glucose control and significant
decrease in insulin requirements after initiation of spinal cord
stimulation. We believe that spinal cord stimulation may provide
additional beneficial effects in patients with chronic pain and
diabetes.
¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@¡@ ¡]
CABG³N«á§Z¶ê¤Õ¥¼³¬©M¤ß©ÐŸ°Êªº¬ÛÃö©Ê
The Association of Patent Foramen Ovale and Atrial Fibrillation
After Coronary Artery
Bypass Graft Surgery
George Djaiani, MD DEAA, FRCA*, Barbara
Phillips-Bute, PhD*, Mihai Podgoreanu, MD*, Robert H.
Messier, MD
,
Joseph P. Mathew, MD*, Fiona Clements, MD*, and Mark F.
Newman, MD*
Departments of *Anesthesiology and
Cardiac
Surgery, Duke University Medical Center, Durham, North Carolina
Anesth Analg 2004;98:585-589
CABG³N«á©ÐŸ(AF)ªºµo¯f²v°ª¡A¼W¥[¤FÂåÀø¸ê·½®ø¯Ó¡C¥»¤å¬ã¨s¤FCABG¯f¤H§Z¶ê¤Õ¥¼³¬(PFO)©M©Ð¶¡¹j°Ê¯ß½F»P³N«áAFµo¯f²vªºÃö«Y¡C1008¨ÒCABG¤â³N¯f¤H¡A³N¤¤³q¹L¸g¹¹D¶WÁn¤ß°Ê¹Ï©ú½T¬O§_¦³©Ð¶¡¹j¯Ê·l¡AºÊ´ú¤â³Nµ²§ô¨ì¥X°|´Á¶¡AFµo¥Í±¡ªp¡Cµ²ªGÅã¥Ü¡G³N«á124¨Ò(12.3%)¨ÖµoAF¡CAF¯f¤H¦h¬°¦~¦Ñªº¯f¤H¡A³N«e±`¦ñ¦³¥R¦å©Ê¤ß¤O°IºÜ¥v¡A³N¤¤§¨³¬®É¶¡ªø¡A³N«á¦í°|®É¶¡©µªø¡CPFO72¨Ò (7.1%)¡A©Ð¶¡¹j°Ê¯ß½F23¨Ò(2.3%)¡C ³N«áAF¯f¤H ¨ÖµoPFO 14¨Ò(19.4%)¡A¨Öµo©Ð¶¡¹j°Ê¯ß½F8¨Ò(34.8%)¡C¥ÎLogistic¦^Âk¤ÀªRÅã¥ÜPFO (´X²v[OR], 1.95; 1.007¡V3.778;
P = 0.047), ¦~ÄÖ(OR, 1.03; 1.015¡V1.053; P = 0.0004)¤Î¥R¦å©Ê¤ß°I¥v(OR, 2.55; 1.671¡V3.900; P < 0.0001)¬O³N«áµo¥ÍAFªº¥ý¥ü¡C
¡]»ôªi¡@Ķ¡@¡@¤ý²»·ç¡@®Õ¡^
Atrial fibrillation (AF) is associated with considerable morbidity and increased resource utilization after coronary artery bypass graft surgery. In this study, we sought to determine whether patent foramen ovale (PFO) and atrial septal aneurysm are associated with an increased risk of postoperative AF in this patient population. We performed a database study on 1008 patients undergoing primary coronary artery bypass graft surgery. All patients were assessed for the development of postoperative AF from the day of surgery to hospital discharge. Atrial septal defects were identified during comprehensive intraoperative transesophageal echocardiographic examination. Postoperative AF was present in 124 (12.3%) patients. Patients with AF were significantly older and had a more frequent incidence of preoperative congestive heart failure, longer cross-clamp time, and prolonged hospital length of stay. PFO was present in 72 (7.1%) and atrial septal aneurysm in 23 (2.3%) patients. In these patients, postoperative AF was present in 14 (19.4%) patients with PFO and 8 (34.8%) patients with atrial septal aneurysm. Multivariate logistic regression analysis identified that PFO (odds ratio [OR], 1.95; 1.007¡V3.778; P = 0.047), age (OR, 1.03; 1.015¡V1.053; P = 0.0004), and history of congestive heart failure (OR, 2.55; 1.671¡V3.900; P < 0.0001) were predictive of postoperative AF.
®a¨ßÀ³¥Î¤û·½©Ê»E¦X¦å¬õ³J¥Õ¹ï°Ê¯ßªº¦å®ê§Î¦¨©M¥X¦åªº§@¥Î
The Effects of a Polymerized Bovine-Derived Hemoglobin
Solution in a Rabbit Model of Arterial Thrombosis and Bleeding
Emmanuel Marret, MD*, Philippe Bonnin, MD PhD
,
Elisabeth Mazoyer, MD
,
Bruno Riou, MD PhD*,
,
Ted Jacobs, MD||, Pierre Coriat, MD*, and Charles-Marc
Samama, MD PhD¶
Departments of *Anesthesiology and Critical Care and
Emergency
Medicine and Surgery, Hôpital Pitié-Salpêtrière,
Paris, France;
Department
of Functional Investigations and
Laboratory
of Hematology, Hôpital Lariboisière, Paris, France; ||Biopure
Corporation, Cambridge, Massachusetts; and ¶Department of Anesthesiology,
Hôpital Avicenne, Bobigny, France
Anesth Analg 2004;98:604-610
¥H¦å¬õ³J¥Õ¬°°ò¦ªº®ñ¸üÅé(HBOCs)¨ã¦³®ñ¦X¥\¯à±`¥Î©ó³N¤¤©Î³Ð¶Ë«á¬õ²ÓM¥N¥Î«~¡AµM¦Ó¨ä¹ï¤î¦å¤è±ªº¼vÅT¥¼²`¤J¬ã¨s¡C¥»¬ã¨s¤ñ¸û¤û·½»E¦X¦å¬õ³J¥Õ(HBOC-201)¡A©ú½¦·»²G©M¥Í²zÆQ¤ô¹ï°Ê¯ß¦å®ê§Î¦¨©M¥X¦åªº¼vÅT¡C¥þ³Â«á¡A30¥uFolts¼Ò«¬®a¨ß¡A¼ÉÅSÀVÁ`°Ê¯ß¨Ã»s³Æ60%ªº¯U¯¶¡A¨Ã«Ø¥ß°Ê¯ßÀ½À£©Ê·l¶Ë¡A«áªÌIJµo¶g´Á©Ê¦å®ê§Î¦¨¡]¶g´Á©Ê¦å¬y´î¤Ö
[CFRs])¡A¦bp¼ÆCFRs°ò¦ȫá¡A°Êª«ÀH¾÷¤À¤T²Õ¡A¨C²Õ10¥u(n = 10)¡G¥Í²zÆQ¤ô(¹ï·Ó²Õ)¡A©ú½¦¡A©MHBOC-201²Õ¡C³q¹L¥H¤U«ü¼Ð¨Ó¤Ï¬MÃĪ«ªº§@¥Î¡G¤£¦P®É´ÁCFRs¦¸¼Æ©M¦Õ¦·ªº¥X¦å®É¶¡¡Cµ²ªGÅã¥Ü¡G©ú½¦©MHBOC-201ªº§@¥Î¬Û¦ü¡ACFRs´î§C®É (¤À§O±q¤¤7¨ì1¡A6¨ì1)¥X¦å®É¶¡ÅãµÛ©µªø(±q88¨ì98s©M81¨ì102s¡F P < 0.05)¡C¥Í²zÆQ¤ô¹ïCFRs©Î¥X¦å®É¶¡µLÅãµÛ¼vÅT¡Cµ²½×¡GHBOC-201©M©ú½¦ªº§@¥Î¬Û¦ü¡A¥i´î¤Ö°Ê¯ß¦å®ê§Î¦¨²v¨Ã©µªø¥X¦å®É¶¡¡C
¡]»ôªi¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Hemoglobin-based oxygen carriers (HBOCs) have been developed primarily for their oxygenating function and possible use as an alternative to red blood cells during surgery or after major trauma. However, their effect on hemostasis has not been studied extensively. We compared the effects on hemostasis of bovine-derived hemoglobin solution (HBOC-201) with gelatin solution and saline infusion in an experimental model of arterial thrombosis and bleeding. After anesthesia, the Folts model was constructed in 30 rabbits. The common carotid artery was exposed, and a 60% stenosis was induced. A compression injury of the artery was then produced, which triggered a series of cyclic episodes of thrombosis (cyclic flow reductions [CFRs]). After the number of baseline CFRs was counted, animals were assigned randomly to one of three groups (n = 10 each): saline (control), gelatin, or HBOC-201 solution. The effect of studied solutions was observed by recording the number of CFRs during another period and was compared with that of saline. Ear immersion bleeding time was recorded after each CFR period. Gelatin and HBOC-201 had similar effects, manifested by significantly decreased CFRs (from median of 7 to 1 and 6 to 1, respectively) and significantly lengthened bleeding time (from 88 to 98 s and 81 to 102 s, respectively; P < 0.05). Saline infusion had no significant effect on CFRs or bleeding time. HBOC-201 and gelatin had similar effects marked by a reduction in the arterial thrombosis rate and increased bleeding time in rabbits.
¤þªy×ô¡B²§¬tîÅ¡B¤C¬tîÅ©M¦a¬tîÅ«D¦í°|³Â¾K«á´_Ĭ±¡ªpªº¤ñ¸û¡G¤@¶µ¨t²Î©Ê¦^ÅU¬ã¨s
Comparison of Recovery Profile After Ambulatory
Anesthesia with Propofol, Isoflurane, Sevoflurane and Desflurane: A Systematic
Review
Anil Gupta, MD FRCA, PhD*,
,
Tracey Stierer, MD*, Rhonda Zuckerman, MD*, Neal Sakima,
MD*, Stephen D. Parker, MD*, and Lee A. Fleisher, MD*
Section Editor
*Department of Anesthesiology and Critical Care, and the
Division of Ambulatory Surgery, Johns Hopkins Medical Institutions, Baltimore,
Maryland and the
Division
for Ambulatory Surgery, Department of Anesthesiology, University Hospital,
Örebro, Sweden
Anesth Analg 2004;98:632-641
¥»¤å¨t²Î©Ê¦^ÅU¬ã¨s¥|ºØ³Â¾K§Þ³Nªº³N«á´_Ĭ©M¨Öµo¯g¡C¨Ï¥Î·j¯Áµü¡§anesthesia¡¨©Mµu¤p¤â³N¡A¨Ã¥B§½¤_¦¨¤H¡]>19·³¡^ªºÀH¾÷¹ï·Ó¹êÅç¡A»y¨¥¬°^»y¡A³q¹LPubMed¡]1966¦Ü2002¦~6¤ë¡^À˯ÁMEDLINE¤Wªº¸ê®Æ®w¡C²Ä¤G¨BÀ˯Á¨Ï¥Î ¡§¤þªy×ô¡¨¡B¡§¦a¬tîÅ¡¨¡B¡§¤C¬tîÅ¡¨©M¡§¦a¬tîÅ¡¨ªº¥ô·N¨âÓµü¡C¿z¿ï«á¦@58½g½×¤å¶i¦æ³Ì«á¤ÀªR¡Cµ²ªGÅã¥Ü¡G¦b¦´Á´_Ĭ¤¤¡A¤þªy×ô©M²§¬tîŨS¦³®t²§¡F¦a¬tîŪº¦´Á´_Ĭn§Ö©ó¤þªy×ô©M²§¬tîÅ¡A¦Ó¤C¬tîŤS§Ö©ó²§¬tîÅ¡C²§¬tîÅ©M¤C¬t¶¡ªº5¤ÀÄÁ©w¦V¤O¦³·L¤p®t²§¡A¦Ó¨ä¥L³Â¾K¾¯¤§¶¡¨S¦³®t²§¡C¦bäú¤ß¡B¹Ã¦R¡BÀYµh©M¥X°|«áäú¤ß¡B¹Ã¦Rµo¥Í²v¤è±¤þªy×ôÀu©ó²§¬tîÅ¡]P<0.05¡^¡C³\¦h§l¤J³Â¾K¾¯²Õªº¯f¤H»P¤þªy×ô²Õ¬Û¤ñ»Ýn¤î¦RÃÄ¡Cµ²½×¡G¤£¦P³Â¾K¾¯¶¡ªº¦´Á´_Ĭ®É¶¡®t²§¤£¤j¡A¦Ó§l¤J©Ê³Â¾K¾¯¥eÀu¡C°Æ¤ÏÀ³µo¥Í²v¤è±¤þªy×ô¸û¤Ö¡A¤×¨ä¬O¥X°|«áäú¤ß©M¹Ã¦R¡C
¡]®ï¤å²W¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
In this systematic review we focused on postoperative recovery and complications using four different anesthetic techniques. The database MEDLINE was searched via PubMed (1966 to June 2002) using the search words "anesthesia" and with ambulatory surgical procedures limited to randomized controlled trials in adults (>19 yr), in the English language, and in humans. A second search strategy was used combining two of the words "propofol," "isoflurane," "sevoflurane," or "desflurane". Screening and data extraction produced 58 articles that were included in the final meta-analysis. No differences were found between propofol and isoflurane in early recovery. However, early recovery was faster with desflurane compared with propofol and isoflurane and with sevoflurane compared with isoflurane. A minor difference was found in home readiness between sevoflurane and isoflurane (5 min) but not among the other anesthetics. Nausea, vomiting, headache, and postdischarge nausea and vomiting incidence were in favor of propofol compared with isoflurane (P < 0.05). A larger number of patients in the inhaled anesthesia groups required antiemetics compared with the propofol group. We conclude that the differences in early recovery times among the different anesthetics were small and in favor of the inhaled anesthetics. The incidence of side effects, specifically postoperative nausea and vomiting, was less frequent with propofol.
¬ü¨Fଥ\¯à©Ê§í¨îN¡Ð¥Ò°òD¡Ð¤Ñ¥V®ò»Ä¨üÅé¦b¤öÃÊßï§Z¥À²ÓM¤¤ªºªí¹F¡G¥ßÅé²§ºcÅé©M¨È³æ¦ìªº®ÄÀ³
Functional Inhibition by Methadone of N-Methyl-D-Aspartate Receptors Expressed in Xenopus Oocytes: Stereospecific and Subunit Effects
Robert J. Callahan, BS*, John D. Au, BS*,
Matthias Paul, MD DEAA
,
Canhui Liu, PhD*, and C. Spencer Yost, MD*
*Department of Anesthesia and Perioperative Care, University
of California, San Francisco, California; and
Department
of Anesthesiology and Intensive Care, University of Cologne, Cologne, Germany
Anesth Analg 2004;98:653-659
¬ü¨Fଡ]Methadone¡^¬O¤@ºØ¦bºC©Ê¯kµhªvÀø¤¤¨Ï¥Î¶V¨Ó¶V¦hªº±j®Äªü¤ùÃþÂíµhÃÄ¡C§@ªÌ¦b¤@¶µ¹q¥Í²z¸ÕÅç¡]¤öÃÊßï¥ú·Æ§Z¥À²ÓM¡^¤¤ÃÒ©ú¨ä¨ã¦³§í¨îN¡Ð¥Ò°òD¡Ð¤Ñ¥V®ò»Ä¨üÅéªí¹F¡C¥~®ø±Û¬ü¨Fଦb·L¼¯º¸¿@«×½d³ò§í¨î©Ò¦³¹«NMDA¨üÅé¨È«¬¡C³o¿@«×»PÃĪ«°Ê¤O¾Ç¬ã¨s¤¤³ø¾ÉªºÁ{§É¦³®Ä¿@«×¬Û¤@P¡C¬Û¤ñ¸û¦Ó¨¥¡A¶Ü°Ø§í¨î³o¨Ç¥\¯à©ÊÂ÷¤l³q¹D©Ò»Ý¿@«×¬OÁ{§É¨Ï¥Î¿@«×8-16¿¡CNR1/2A©MNR1/2B¨È«¬½Æ¦XÅé¹ï¬ü¨F଩M¶Ü°Øªº§í¨î§@¥Î¸ûNR1/2C©MNR1/2D¨È«¬½Æ¦XÅé§ó¬°±Ó·P¡C¦b¥~®ø±Û¬ü¨Fଦs¦bªº±¡ªp¤U¡A³Ì¤jNMDA¨ë¿E¹q¬yÅãµÛ¼W¤j¡A¦ý²£¥Í50%³Ì¤j¬¡°ÊªºNMDA¿@«×§ïÅܤ£¤j¡A³o»¡©ú¬ü¨Fଳq¹L«DÄvª§¾÷¨î§í¨î¡CÁöµM¬ü¨Fପº¥ßÅé²§ºcÅé¦b³\¦h¨È«¬¤¤Åã¥Ü¤F³Ì¤pªº¥ßÅé¿ï¾Ü©Ê¡A¦ýR(-)¬ü¨Fହï§í¨îNR1/2A½Æ¦XÅ馳°ª«×¿ï¾Ü©Ê¡C³o¨Çµ²ªG´£¨Ñ¤F¬ü¨Fଧí¨îNMDA¨üÅ鬡°Êªº¶i¤@¨B¸ê®Æ¡A¨äÃIJz§@¥Î¬O³q¹Lªü¤ùÃþ¨üÅé©MNMDA¨üÅé¦@¦P°_§@¥Î¡C
¡]®ï¤å²W¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Methadone is a strong opioid analgesic that is finding increasing use in chronic pain therapeutics. We explored its reported efficacy for inhibiting N-methyl-D-aspartate (NMDA) receptors in a functional electrophysiologic assay (Xenopus laevis oocyte expression). Racemic methadone inhibited all subtypes of rat NMDA receptors with derived 50% inhibitory concentrations in the low micromolar range. These concentrations overlap with clinically achievable concentrations reported in pharmacokinetic studies. In contrast, morphine inhibited these functional ion channels only at 8¡V16 times larger concentrations. The NR1/2A and NR1/2B subtype combinations were in general significantly more sensitive to inhibition by methadone and morphine compared with the NR1/2C and NR1/2D subtypes. In the presence of racemic methadone, the maximum NMDA-stimulated currents were markedly decreased, but the NMDA concentration producing 50% of maximal activation was altered only slightly, indicating that methadone blocks by a noncompetitive mechanism. Although stereoisomers of methadone showed minimal stereoselectivity in most subtypes, R(-) methadone was highly selective in its inhibition of the NR1/2A combination. These results provide further functional data describing the NMDA receptor inhibitory actions of methadone and support the hypothesis that methadone acts through both opioid and NMDA receptor mechanisms.
·sl¥Íª«N-¥Ò°ò¦h¼{¥»P¦h¼{¥©M¥¬¤ñ¥d¦]§@¬°§½³¡³Â¾KÃįS©Êªº¤ñ¸û
Local Anesthetic Properties of a Novel Derivative, N-Methyl Doxepin, Versus Doxepin and Bupivacaine
Yukari Sudoh, MD*, Elaine Elliott Cahoon, BS*,
Umberto De Girolami, MD
,
and Ging Kuo Wang, PhD*
*Department of Anesthesiology, Perioperative and Pain
Medicine, Brigham and Women¡¦s Hospital; and
Department
of Pathology, Brigham and Women¡¦s Hospital and Children¡¦s Hospital and Harvard
Medical School, Boston, Massachusetts
Anesth Analg 2004;98:672-676
¦b¦UºØ¤TÀôÃþ§Ü§íÆ{ÃĤ¤¡A¦h¼{¥©Mªü¦Ì´ÀªL¤]¬Oªø®Äªº§½³ÂÃÄ¡C§@ªÌ¦X¦¨¤F¤@·sªº¤Æ¦Xª«N-¥Ò°ò¦h¼{¥¨Ã¬ã¨s¨ä§½³¡³Â¾Kªº§@¥Î¯S©Ê¡C¨ú¤j¹«ªº§¤°©¯«¸g¡A´ú¸Õ2.5¡A5.0¡A10mM N-¥Ò°ò¦h¼{¥©M¦h¼{¥¹ï¥»Åé·Pı¡A¹B°Ê¥H¤Îµhıªýº¢ªº®ÄªG¨Ã»P0.5%ªº¥¬¤ñ¥d¦]§@¹ï¤ñ¡F³q¹L¹qÀ£¹X¨î³N¤U´ú¸Õ°ö¾i««Åé½F²ÓM¨Óµû¦ôN-¥Ò°ò¦h¼{¥©M¦h¼{¥¹ïNaÂ÷¤l³q¹Dªºªýº¢±¡ªp¡Cµ²ªGÅã¥Ü¡GN-¥Ò°ò¦h¼{¥¤Þ°_§¹¥þªº¯«¸gªýº¢®É¶¡ªø©ó¦h¼{¥¡]¨Ò¦p¡A¦b10mM®É¤À§O¬O7.4¤p®É©M5.3¤p®É¡^¡C§@ªÌµo²{¦b¦UºØ¿@«×±¡ªp¤Uªº¥\¯à§¹¥þ«ì´_®É¶¡¦³ÅãµÛ®t²§¡A°£¤F2.5mM¿@«×¥~§¹¥þªýº¢®É¶¡¤]¦³ÅãµÛ®t²§¡C0.5%¥¬¤ñ¥d¦]¡]15.4mM¡^§¹¥þªýº¢®É¶¡¡]¬ù1.5¤p®É¡^¤Ö©óN-¥Ò°ò¦h¼{¥©M¦h¼{¥¡CN-¥Ò°ò¦h¼{¥©M¦h¼{¥¬O¼ç¦bªºNaÂ÷¤l³q¹Dªýº¢¾¯¡A¦ýN-¥Ò°ò¦h¼{¥²M°£²vºC¤_¦h¼{¥¡Cµ²½×¡GN-¥Ò°ò¦h¼{¥¬O¤@¼ç¦bªºNaÂ÷¤l³q¹Dªýº¢¾¯¥B¬O¤@ªø®Ä§½³¡³Â¾K¾¯¡C
¡]¦¶½÷¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Among various tricyclic antidepressants, doxepin and amitriptyline are also long-acting local anesthetics. We synthesized a new compound, N-methyl doxepin, and investigated whether this derivative possesses local anesthetic properties. N-methyl doxepin and doxepin were tested in a rat sciatic nerve model at 2.5, 5.0, and 10 mM. Proprioceptive, motor, and nociceptive blockade were evaluated and compared with those induced by 0.5% bupivacaine. Block of Na+ channels by N-methyl doxepin and doxepin was assessed in cultured pituitary tumor cells under voltage clamp conditions. N-methyl doxepin elicited complete nociceptive blockade that generally lasted longer than that caused by doxepin (e.g., approximately 7.4 h versus 5.3 h at 10 mM). Significant differences were observed for full recovery of function at all concentrations and for the duration of complete blockade except at 2.5 mM. Bupivacaine at 0.5% (15.4 mM) was less effective in producing complete blockade (approximately 1.5 h) than N-methyl doxepin and doxepin. Both doxepin and N-methyl doxepin were potent Na+ channel blockers, although N-methyl doxepin displayed a slower wash-in rate. No morphological alterations were detected in cross-sectioned sciatic nerve specimens with these three drugs. We conclude that N-methyl doxepin is a potent Na+ channel blocker and a long-acting local anesthetic for rat sciatic nerve blockade.
§C¯×²§¤þ×ô¨Å¾¯»P¼Ð·Çªº²§¤þ×ô¨Å¾¯ªºÃĮĤñ¸û
The Pharmacodynamic Effects of a Lower-Lipid Emulsion of
Propofol: A Comparison with the Standard Propofol Emulsion
Dajun Song, MD PhD, Mohamed Hamza, MD, Paul F. White, PhD MD, Kevin Klein, MD, Alejandro Recart, MD, and Omeed Khodaparast, MS
From the Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas
Anesth Analg 2004;98:687-691
·sÃĪ«¡X¡X§C¯×²§¤þ×ô¨Å¾¯¡]Ampofol¡^¡A¥¦§t¦³1%ªº²§¤þ×ô¡A5%ªº¨§ªo¥H¤Î0.6%ªº§ZÁC¯×¡C§@ªÌÀH¾÷¡BÂùª¼¬ã¨s63¦W°·±dªºªù¶E¯f¤H¡§¥¿Å¡¨³Â¾K®ÉÀ³¥Î§C¯×²§¤þ×ô¨Å¾¯©Î²§¤þ×ô¨Å¾¯(Diprivan)¤ñ¸û¨ä°_®Ä®É¶¡¡B»¤¾É©Mºû«ù®Éªº§@¥Î®ÄªG¡CÀR¯ßª`®gµÎªâ¤Ó¥§0.1£gg/kg¡]©Îªâ¤Ó¥§1£gg/kg¡^©M²§¤þ×ô2mg/kg¡A¨Ï¥Î¤@¥i½Õ¸`²§¤þ×ô³t²vªº±Àª`¬¦ÀR¯ßºû«ù¡A³t²v¦b120-200£gg¡Ekg-1¡Emin-1¡C°O¿ý¤U·û¤ò¤Ï®g®ø¥¢®É¶¡©M°±¤îª`®gªº®É¶¡¡A¨Ã¥Bµû¦ôª`®g®É¯kµhªºµ{«×¡A»¤¾É³t«×¡A³N¤¤¦å¬y°Ê¤O¾ÇªºÅܤƥH¤ÎÂùÀW«ü¼Æ¡A¸C²´®É¶¡©M©w¦ì«ì´_®É¶¡¡Cµ²ªGÅã¥ÜAmpofol©MDiprivan¦b°_®Ä®É¶¡¡A»¤¾É³t«×¡A³Â¾K©Ò»Ýªº¾¯¶q¡AÂùÀW«ü¼Æ¡A¦å¬y°Ê¤O¾Ç«ü¼Ð¡A«ì´_«ü¼Ð¥H¤Î±wªÌªºº¡·N«×³£¨S¦³©úÅ㪺®t²§¡Cª`®g®É¯kµhªºµo¥Í²vAmpofol²Õ°ª©óDiprivan²Õ¡]26%©M6%¡AP¡q0.05¡r¡Cµ²½×¡GAmpofol¦b³Â¾K©Ê¯à»PDiprivan¬Û¦P¡A¦ýª`®g¯kµhµo¥Í²v°ª©ó«áªÌ¡C
¡]¦¶½÷¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Using a randomized, double-blind protocol design, we compared a new lower-lipid emulsion of propofol (Ampofol®) containing propofol 1%, soybean oil 5%, and egg lecithin 0.6% with the most commonly used formulation of propofol (Diprivan®) with respect to onset of action and recovery profiles, as well as intraoperative efficacy, when administered for induction and maintenance of general anesthesia as part of a "balanced" anesthetic technique in 63 healthy outpatients. Anesthesia was induced with sufentanil 0.1 µg/kg (or fentanyl 1 µg/kg) and propofol 2 mg/kg IV and maintained with a variable-rate propofol infusion, 120¡V200 µg ¡E kg-1 ¡E min-1. Onset times to loss of the eyelash reflex and dropping a syringe were recorded. Severity of pain on injection, speed of induction, intraoperative hemodynamic variables, and electroencephalographic bispectral index values were assessed. Recovery times to opening eyes and orientation were noted. The results demonstrated that there were no significant differences between Ampofol® and Diprivan® with respect to onset times, speed of induction, anesthetic dose requirements, bispectral index values, hemodynamic variables, recovery variables, or patient satisfaction. However, the incidence of pain on injection was more frequent in the Ampofol® group (26% versus 6%, P < 0.05). We conclude that Ampofol® is equipotent to Diprivan® with respect to its anesthetic properties but was associated with a more frequent incidence of mild pain on injection.
¤j¤â³N«á¯f¤Hµw½¤¥~¦Û±±Âíµh¡]PCEA¡^ªvÀø³N«á¯kµhªº¶O¥Î¤ñ¸û
Cost Drivers in Patient-Controlled Epidural Analgesia for
Postoperative Pain Management After Major Surgery
Martin Schuster, MD, MA, André Gottschalk, MD, Marc Freitag, MD, and Thomas Standl, MD Section Editor
Department of Anesthesiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
Anesth Analg 2004;98:708-713
§@ªÌ¦^ÅU©Ê¬ã¨s¤F350¨Ò¤j¤â³N«áÀ³¥ÎPCEAªvÀø³N«á¯kµh¡]¥]¬A¸¡³¡¡B¯Ý³¡¡B¤â³N¡B°ü²£¬ì©M¾ã§Î¥~¬ì¤â³N¯f¤H¡^ªºÀø®Ä¡BÀøµ{©M¤èªk¡C³N«á²Ä¤@¤Ñ©M²Ä¤T¤Ñªº¥§¡¯kµhµû¤À¤À§O¬°16¡Ó23©M9¡Ó16¡]µøÄ±Ãþ¤ñµû¤À½d³ò¡A0-100¡^¡C¥þ³Â¯f¤H¥§¡Àøµ{¬°4.9¡Ó2.2¤Ñ¡A°ü²£¬ì¯f¤H¬°5.2¡Ó3.1¤Ñ¡A¾ã§Î¥~¬ì¯f¤H¬°4.5¡Ó2.8¤Ñ¡Cµw½¤¥~µÄª`®g§½³ÂÃÄ©Mªü¤ùÃþÃĪ«²V¦X²GªºÁ`¶q¦b¥þ³Â¯f¤H¬°707¡Ó507ml¡A°ü²£¬ì¯f¤H¬°770¡Ó576ml¡A¾ã§Î¥~¬ì¯f¤H¬°593¡Ó456ml¡C©Ò¦³PCEAªvÀø¹Lµ{¤¤ªºÁ`¶O¥Î¬°447¡Ó218/¨Ò¡]1Ó³æ¦ì¬ù¬°1¬ü¤¸¡^¡C¨ä¤¤51%¬°Âå°È¤Hûªºªá¶O¡A20%¬°ÃĶO¡A15%¬°PCEA¬¦©M¬¦§÷®Æ¶O¡A13%¬°ì¥ý¾ÉºÞ¸m¤Jªº¶O¥Î¡C®Ú¾Ú³o¨Ç¶O¥Î©M´î¤Ö¶O¥Îªº¥i¦æ©Ê¡A«ØÄ³¨Ï¥ÎPCEA«ápºâ¶O¥Î¡C¥Ñ©ó¨Ï¥ÎPCEAªº¶O¥Î¥Dn¬OÃĶO©MÂå°È¤Hûªº¤ä¥X¡A©Ò¥HÀ³¸Ó¦Ò¼{°±¤îPCEA«á´ÁºÊ´ú¨Ã¹w¥ý½T©w¨ä¥L³~®|¡C
¡]Êã¬öµØ¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
In this retrospective study, we determined efficiency,
treatment length, and resource use for postoperative pain management
with patient-controlled epidural analgesia (PCEA) in 350 consecutive
patients undergoing major abdominal, thoracic, gynecological, or
orthopedic surgery. Average pain scores on a visual analog scale
were 16 ¡Ó 23 and 9 ¡Ó 16 (visual analog scale range, 0 to 100) on
postoperative Days 1 and 3, respectively, and were similar among
groups. The treatment length was 4.9 ¡Ó 2.2 days in general surgical,
5.2 ¡Ó 3.1 days in gynecological, and 4.5 ¡Ó 2.8 days in orthopedic
patients. The total volumes of the mixture of local anesthetic and
opioid received epidurally were 707 ¡Ó 507 mL, 770 ¡Ó 576 mL,
and 593 ¡Ó 456 mL in the general surgical, gynecological, and
orthopedic groups, respectively. The average total costs for all
groups for the full treatment course with PCEA were
447 ¡Ó
218 per case (1 equals
approximately US$1). Fifty-one percent of these costs were staff
costs, 20% were costs for the applied drugs, 15% were costs for PCEA
pumps and pump material, and 13% were costs for the initial catheter
insertion. In the light of these costs and the availability of less
costly alternatives, measurements for cost containment by using PCEA
are recommended. Because treatment length is the main cost driver
both for drug and staff costs, close monitoring of treatment length
and a predefined migration path to alternative techniques after PCEA
should be considered.
¦Û¥Ñ¬¡°Ê¤j¹«Áp¦XÀ³¥Îª½¬y©M¥æ¬y¹q¶i¦æ¸gÆ`¹q¨ë¿Eªº§Ü¶Ë®`§@¥Î
The Antinociceptive Effect of Transcranial
Electrostimulation with Combined Direct and Alternating Current in Freely
Moving Rats
Vladimir Nekhendzy, MD*, Christo P. Fender, BA*,
M. Frances Davies, PhD*, Hendrikus J. M. Lemmens, MD, PhD*,
Michael S. Kim, MD*, Donna M. Bouley, DVM, PhD
,
and Mervyn Maze, MBChB, FRCP, FRCA
Departments of *Anesthesiology and
Comparative
Medicine, Stanford University School of Medicine, Stanford, California, and the
Department
of Anaesthetics and Intensive Care, Imperial College, London and Chelsea and
Westminster NHS Hospital Trust, London, UK
Anesth Analg 2004;98:730-737
¾Ú³ø¾É¸gÆ`¹q¨ë¿E¡]TES¡^¥i¥H»¤µo©úÅ㪺Âíµh§@¥Î¡A¨Ï³N«eªü¤ùÃþÃĪ«ªº¥Î¶q´î¤Ö¡C¥Ñ©ó¯Ê¤ÖÁ{§É¹ï·Ó¹êÅç©MTESÂíµh§@¥Îªº°Êª«¹êÅç¡ATESÁ{§ÉÀ³¥Î¨üªý¡C³o¨Ç«D¨M©w©Êªº¸ê®Æ¥i¥H³¡¤À¸ÑÄÀ¬°TES¹q·¥¸m©ó¥Ö½§®É¡A¦b¤HÃþÀ³¥Îªº¦UºØ¨ë¿EµLªk¥Î©ó¤p¹«¡C¥»¹êÅ礤¡A§@ªÌ±Ä¥Î¨ë¿E§Î¦¡»PÁ{§É¬Û¦ü·sªº°Êª«¼Ò«¬¡AÃÒ¹êTESªº§Ü¶Ë®`§@¥Î¡C§Ü¶Ë®`§@¥Î³q¹L´ú¶q²M¿ô¡B¦Û¥Ñ¬¡°Ê¶¯¹«¹ï§¨§À¡B¼öªO¸ÕÅç¶Ë®`¨ë¿EìHȨӵû¦ô¡CÀ³¥Î2.25mAªºTES²£¥Í§Ö³t¡B«ùÄò¡BÀW²v¨Ì¿à©Ê¡]40-60Hz¡^ªº§Ü¶Ë®`§@¥Î,¥i¹F³Ì¤jÈ50%¡Cµ²½×¡G¤j¹«¸g¥ÖTES¨ã¦³§Ü¶Ë®`§@¥Î¡C³oºØ§@¥Îªº¯SÂI´£¥Ü¤j¹«ÀY¥Ö¤¤ªº·Pı¯«¸g¦b¸gTES¤¶¾Éªº§Ü¶Ë®`§@¥Î¤¤°_«n§@¥Î¡C
¡]Êã¬öµØ¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Transcranial electrostimulation (TES) has been reported to elicit significant analgesia, allowing a substantial reduction of intraoperative opioids. Acceptance of TES into clinical practice is hampered by lack of controlled clinical trials and inconclusive animal data regarding the TES antinociceptive action. This inconclusive data may be explained, in part, by failure in rat experiments to simulate the variables used in humans when TES electrodes are positioned on the skin. In this study we validated the TES antinociceptive effect in a novel animal model of cutaneously administered TES, when the stimulating conditions mimic the ones used in clinical practice. The antinociceptive effect was assessed by measuring nociceptive thresholds in the tail-flick and hot-plate latency tests in awake, unrestrained male rats. Data were analyzed by analysis of variance and mixed-effects population modeling. The administration of TES at 2.25 mA produced an almost immediate, sustained, frequency-dependent (40¡V60 Hz) antinociceptive effect, reaching approximately 50% of the maximal possible value. We conclude that an antinociceptive effect of cutaneously administered TES can be demonstrated in the rat. Some characteristics of the effect suggest an important role of the sensory nerves of the rat¡¦s scalp in mediating the TES antinociceptive response.
Is Physician Anesthesia Cost-Effective?
J. P. Abenstein, MSEE MD*, Kirsten Hall Long, PhD
,
Brian P. McGlinch, MD*, and Niki M. Dietz, MD* Section
Editor
*Department of Anesthesiology and
Division
of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota
Anesth Analg 2004;98:750-757
³Â¾K¤¤¤@ӳ̦³ª§Ä³ªº°ÝÃD¬O¡G¦b³Â¾K¤u§@¤¤¬O§_«DÂå¾Ç±M·~ªº³Â¾K®v¤ñÂå®v³Â¾K§ó¨ã¦³¦¨¥»®Ä¯q¡H§@ªÌ½Õ¬d¬ü°ê³Â¾K¤ä¥I¶O¥Î¨Óµû¦ô¨ä¦¨¥»¡C§Q¥Î¤ä¥I³Â¾K¶O¥Îªº½Õ¬d¸ê®Æ©M¬ã¨sµ²ªG¡A«Ø¥ß°_¤@ºØ¯S©wªº¼Ò¦¡¨Ó¤ñ¸ûÂå®v³Â¾K»P«DÂå®v³Â¾Kþ¤@ºØ§ó¸gÀÙ¡C¦¨¥»®Ä¯q²v©w¸q¬°¡G³Â¾KÂå®vªº¦¨¥»¤ñ¤W³oºØ¼Ò¦¡±a¨Óªº¹w´Á¹Ø©R¼W¥[¡]§Y¶O¥Î/¹Ø©R¼W¥[[$/YLS]¡^¡Cµ²ªGªí©úÂå®v³Â¾K¥i¥H°§C¦¨¥»¡A¥[¤J«OÀIªº«C¦~±wªÌ¦¨¥»®Ä¯q²v¬°-$2,601/YLS¡A¥[¤J«OÀIªº¦Ñ¦~±wªÌ¹w´Á¦¨¥»®Ä¯q²v¬°-$4,410/YLS¡C¤@¤¸©Î¦h¤¸±Ó·P¤ÀªRªí©ú¦¨¥»®Ä¯q²v½d³ò¦b-$4,410 ¡Ð $38,778/YLS¤§¶¡¡Cµ²ªG¹ï¤Ï¬M°²©wªº¤ä¥I®t§O©M°²©wªº¦º¤`²v«D±`ºë½T¡C³oºØ¤ÀªR¬°¤ä´©Âå®v³Â¾K¼Ò¦¡´£¨Ñ¤F¸gÀپǪºÃÒ¾Ú¡C
¡]¦¶¼zµ`¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
One of the most controversial issues in anesthesia is whether nonmedically directed nurse anesthetists are relatively more cost-effective than anesthesiologists in the provision of anesthesia care. We electronically surveyed anesthesia practices throughout the United States to estimate the range in anesthesia professional costs from the payer perspective. Using this survey data on anesthesia reimbursement and published outcomes studies, we developed an ad hoc model to estimate the cost-effectiveness of physician-directed anesthesia relative to a nonmedically directed nurse anesthetist model of care from the payer perspective. Cost-effectiveness ratios were defined as the ratio of incremental costs associated with physician anesthesia relative to the estimated incremental life expectancy gains with this model of care (i.e., dollars per year of life saved [$/YLS]). Reference case results suggest that physician anesthesia is cost saving with an estimated incremental cost-effectiveness ratio of -$2,601/YLS for a younger privately insured patient and an estimated cost-effectiveness ratio of -$4,410/YLS for an elderly Medicare insured patient. Cost-effectiveness ratios ranged from -$4,410 to $38,778/YLS in univariate and multivariate sensitivity analyses across payer types. Results were most sensitive to assumed differences in reimbursement (commercial conversion factors) and to mortality rate assumptions by provider type. This analysis offers economic evidence in support of the physician anesthesia model of care.
¹w¨¾©Ê¨Ï¥ÎfµÇ¤W¸¢¯À¥i¨¾¤î帡²£¤â³N¤¤¦]¯á³Â¤Þ°_ªº§C¦åÀ£
Prophylactic Phenylephrine Infusion for Preventing
Hypotension During Spinal Anesthesia for Cesarean Delivery
Warwick D. Ngan Kee, MBChB MD, FANZCA, Kim S. Khaw, MBBS FRCA, Floria F. Ng, RN BASc, and Bee B. Lee, MBBS FANZCA
Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China
Anesth Analg 2004;98:815-821
¦b¤@¦¸ÀH¾÷ªº¹ï·Ó¹êÅ礤¡A§@ªÌ¬ã¨s¤F帡²£¤â³N¤¤¹w¨¾©Ê¨Ï¥ÎfµÇ¤W¸¢¯À¹ïÁ×§K¯áÅè³Â¾K¤Þ°_ªº§C¦åÀ£ªº§@¥Î¡C¦bÀT¤ºª`ÃÄ«áÀH§Y¨Ï¥ÎfµÇ¤W¸¢¯À100£gg/min¡]n=26¡^«ùÄò3¤ÀÄÁ¡C¦bL¨à¨ú¥X¤§«e¨C¤ÀÄÁ´ú¶q¤@¦¸¦åÀ£¡AY°Ê¯ß¦¬ÁYÀ£¡]SAP¡^§C©ó¥¿±`¤ô¥«Kµ¹¤©fµÇ¤W¸¢¯À100£gg/min¡C¹ï·Ó²Õ¡]n=24¡^¦bSAP¤p©ó¥¿±`¤ô¥ªº80%®Éµ¹¤©fµÇ¤W¸¢¯À100£gg¡C»P¹ï·Ó²Õ¬Û¤ñ«ùÄòª`®gfµÇ¤W¸¢¯À¯à´î¤Ö§C¦åÀ£ªºµo¥Í²v¡]6/26¡]23%¡^¡F¹ï·Ó²Õ¬°21/24¡]88%¡^¡FP<0.0001¡^¡A¦P®É¤]¯à´î»´¦åÀ£¤U°ªºµ{«×¡]¥§¡³Ì§CªºSAP¬°106mmHg,ªi°Ê´T«×¬°95¡X111mmHg;¹ï·Ó²Õ¬°80mmHg,73¡X93mmHg¡FP<0.0001¡^¡C¤ß²v¤]¸û¹ï·Ó²ÕºC¡]P<0.0001¡^¡C¹êÅç²ÕfµÇ¤W¸¢¯À¾¯¶q¡]1260£gg¡Ó; 1010--1640£gg¡^¤j©ó¹ï·Ó²Õ¡]450£gg¡A300--750£gg¡FP<0.0001¡^¡A¦ýÂÀ±a¦å®ð©MApgarµû¤À¬Û¦ü¡C¨C²Õ§¡¦³¤@ÓL¨àªºÂÀ±a¦åPH<7.2¡Cµ²½×¡G¯áÅè³Â¾K¤U帡²£¯f¤H¹w¨¾©Ê¨Ï¥ÎfµÇ¤W¸¢¯À¥i²³æ¡B¦w¥þ¡B¦³®Ä¦a±±¨î³N¤¤¦åÀ£¡C
¡]¦¶¼zµ`¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
In a randomized, double-blinded, controlled trial, we investigated the prophylactic infusion of IV phenylephrine for the prevention of hypotension during spinal anesthesia for cesarean delivery. Immediately after intrathecal injection, phenylephrine was infused at 100 µg/min (n = 26) for 3 min. From that point until delivery, phenylephrine was infused at 100 µg/min whenever systolic arterial blood pressure (SAP), measured each minute, was less than baseline. A control group (n = 24) received IV bolus phenylephrine 100 µg after each measurement of SAP <80% of baseline. Phenylephrine infusion decreased the incidence (6 [23%] of 26 versus 21 [88%] of 24; P < 0.0001), frequency, and magnitude (median minimum SAP, 106 mm Hg; interquartile range, 95¡V111 mm Hg; versus median, 80 mm Hg; range, 73¡V93 mm Hg; P < 0.0001) of hypotension compared with control. Heart rate was significantly slower over time in the infusion group compared with the control group (P < 0.0001). Despite a large total dose of phenylephrine administered to the infusion group compared with the control group (median, 1260 µg; interquartile range, 1010¡V1640 µg; versus median, 450 µg; interquartile range, 300¡V750 µg; P < 0.0001), umbilical cord blood gases and Apgar scores were similar. One patient in each group had umbilical arterial pH <7.2. Prophylactic phenylephrine infusion is a simple, safe, and effective method of maintaining arterial blood pressure during spinal anesthesia for cesarean delivery.
¦a¥d¦]¼W¥[¯«¸g¥ÍªøÀ@²ÓM¤º¶tÂ÷¤l
Intracellular Calcium Increases in Growth Cones Exposed
to Tetracaine
Shigeru Saito, MD, Inas A. M. Radwan, MD, Koichi Nishikawa, MD, Hideaki Obata, MD, Tomonori Okamoto, MD, Toshio Kanno, MD, and Fumio Goto, MD
From the Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan
Anesth Analg 2004;98:841-845
§½³ÂÃĹ令¼ô©M¥¿¦b¥Íªøªº¯«¸g¤¸ªº¬r©Ê§@¥Î§¡¤w¦³³ø¾É¡C¥»¹êÅç§@ªÌ¬ã¨s¦a¥d¦]¦b¥ÍªøÀ@°I°hªº¹Lµ{¤¤¬O§_¤Þ°_Ca2+¿@«×¤É°ª¡C¥ÍªøÀ@¼ÉÅS©ó¦a¥d¦]¤§«á¡A³q¹Lfura2/AM´ú©wCa2+¿@«×¡Aµo²{¦a¥d¦]¡]1¡Ð2mM¡^¤Þ°_¥ÍªøÀ@²ÓM¤ºªºCa2+¿@«×¤É°ª¡]P<0.01¡^. Ca2+ªº¼öÂI¥¬±q¥~©P¦V²ÓMÅé¤À§Gª½¦Ü¯«¸g¬ð¡C¦bµLCa2+ªº°ö¾i°ò¤¤¡A¦a¥d¦]§@¥Î©ó¥ÍªøÀ@¡ACa2+¿@«×ªº¼W¥[«Ü¤p¡A¦ý¾ÉP¤F¥ÍªøÀ@ªº°I°h¡CNi2+(100Um;¤@ºØCa2+ªýº¢¾¯)©MBAPTA-AM(5Um; ²ÓM¤ºCa2+îg¦X¾¯)¤£¯à§í¨î1¡Ð2mM¦a¥d¦]¾ÉP¥ÍªøÀ@°I°h¡Cµ²½×¡G¦a¥d¦]¡]>1Mm¡^ ¦P®É¤Þ°_¥ÍªøÀ@°I°h©MCa2+¿@«×¼W¥[¡A³o¨âºØ²{¶H¥i¯à¬O¿W¥ßµo¥Íªº¡C
¡]³¯¼ä¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Neurotoxicity of local anesthetics has been reported for both matured and growing neurons. In the present study, we examined if tetracaine increases Ca2+ concentration during growth cone collapse. Intracellular Ca2+ concentration was measured by fura 2/AM after exposure to tetracaine. Tetracaine (1¡V2 mM) induced increases in intra-growth cone Ca2+ concentration (P < 0.01). The Ca2+ hot spot was expanded into the neurite from the periphery towards the cell body. When tetracaine was applied to growth cones in Ca2+ free media, the increase was minor. However, tetracaine induced growth cone collapse even in the culture media, which did not contain Ca2+. Ni2+ (100 µM; a general Ca2+ channel inhibitor) and BAPTA-AM (5 µM; intracellular Ca2+ chelator) could not inhibit growth cone collapse induced by 1¡V2 mM tetracaine. Tetracaine (>1 mM) induces collapse and Ca2+ increase at growth cones simultaneously; however, these two
phenomena might be provoked independently.
The Intubating Laryngeal Mask Airway Facilitates Tracheal
Intubation in the Lateral Position
Ryu Komatsu, MD*, Osamu Nagata, MD*,
Daniel I. Sessler, MD
,
and Makoto Ozaki, MD*
*Department of Anesthesiology, Tokyo Women¡¦s Medical
University, Tokyo, Japan, and the
Outcomes
ResearchTM Institute and Departments of Anesthesiology and
Pharmacology, University of Louisville, Louisville, Kentucky
Anesth Analg 2004;98:858-861
ÁöµM°¼ª×¦ì®ðºÞ´¡ºÞªº§xÃøµ{«×¨S¦³¸g¹L¨t²Îªºµû»ù¡A¦ý°¼ª×¦ì¤¸¤â³N®É®ð¹DÅã¥Ü§xÃø·|¤Þ°_¦MÀIªºµ²ªG¡C§@ªÌ½Õ¬d³ï¸n¸m¤J¡]ILMA¡^¬O§_¯àÀ°§U®ð¹D¸Ñ奿±`ªº±wªÌªº®ðºÞ´¡ºÞ¡A°¼ª×¦ì®ÉMallampatiµû¤À≤3¡A¥õÀY¶ZÂ÷≥5cm¡C³q¹L¦¨¥\²v©M´¡ºÞ®É¶¡¨Óµû»ù³oºØ§Þ³N¬O§_¯à§@¬°¤â³N¤¤°¼ª×¦ì±wªÌ§xÃø´¡ºÞ®Éªº¸É±Ï±¹¬I¡C¿ï¾Ü¬°50¡A¨Ò±µ¨ü¸y´Õ¶¡½L¬ð¥X¤â³N¡]°¼ª×¦ì¡^©M50¨Ò¨ä¥L¤â³N¡]¥õª×¦ì¡^¡A³Â¾K»¤¾É¥ÎÃĬ°²§¤þ×ô©Mªâ¤Ó¥§¡C¸y´Õ¤â³N±wªÌ³Â¾K»¤¾É«e¨ú¥ª°¼©Î¥k°¼ª×¦ì¡A´¡ºÞ¤]±Ä¥Î¦P¼ËªºÅé¦ì¡A¹ï·Ó²Õ»¤¾É©M´¡ºÞ§¡±Ä¥Î¥õª×¦ì¡C¨â²Õ§¡¨Ï¥ÎLIMAª¼´¡¡A°O¿ý´¡ºÞªº®É¶¡©M»Ýn½Õ¾ã´¡ºÞ¨Ò¼Æ©M¤è¦¡µ¥¡C¨Ï¥ÎMann-Whitney U , Fisher¡¦s exact
test,X2©Î«D¦¨¹ïStudent¡¦s t ²Îp¤ÀªR¡Cµ²ªG¡G¨â²Õ¯f¤H¤@¯ë±¡ªp©M®ð¹D´ú¶q±¡ªp¬Û¦ü¡F°¼ª×¦ì²Õ±i¤fµ{«×µy¤j¡]5.1¡G4.6cm¡^¡F¨â²Õ®ðºÞ´¡ºÞ®É¶¡¬Ûªñ¡]25s¡^¡A´¡ºÞ¦¨¥\²v¤]¤@¼Ë¡]96¢H¡^¡Cµ²½×¡G§Y¨Ï¦b°¼ª×¦ì¡AILMA´£¨Ñ¤Fº¡·Nªº´¡ºÞ¦¨¥\²v©M´¡ºÞ®É¶¡¡]<1min¡^¡C
¡]³¯¼ä¡@Ķ¡@¤ý²»·ç¡@®Õ¡^
Although the difficulty of tracheal intubation in the
lateral position has not been systematically evaluated, airway loss
during surgery in a laterally positioned patient may have hazardous consequences.
We explored whether the intubating laryngeal mask airway (ILMA)
facilitates tracheal intubation in patients with normal airway
anatomy, i.e., Mallampati grade
3
and thyromental distance
5
cm, positioned in the lateral position. We evaluated whether this
technique can be used as a rescue when the airway is lost during the
middle of surgery in laterally positioned patients with respect to
success rate and intubation time. Anesthesia was induced with
propofol, fentanyl, and vecuronium in 50 patients undergoing spine
surgery for lumbar disk herniation (Lateral) and 50 undergoing other
surgical procedures (Supine). Patients having disk surgery (Lateral)
were positioned on their right or left sides before induction of
general anesthesia, and intubation was performed in that position.
Patients in the control group (Supine) were anesthetized in supine
position, and intubation was performed in that position. Intubation
was performed blindly via an ILMA in both groups. The time required
for intubation and number and types of adjusting maneuvers used were
recorded. Data were compared by the Mann-Whitney U test, Fisher¡¦s exact test,
2
test, or unpaired Student¡¦s t-test, as appropriate. Data presented as mean (SD). Demographic and
airway measures were similar in the two groups, except for mouth
opening, which was slightly wider in patients in the lateral position:
5.1 (0.9) versus 4.6 (0.7) cm. The time required for intubation was
similar in each group (
25
s), as was intubation success (96%). We conclude that blind
intubation via an ILMA offers a frequent success rate and a
clinically acceptable intubation time (<1 min) even in the
lateral position.
«D¤ßŦ¤â³N³N¤¤¤ß¦åºÞ¨Æ¥óªºµo¥Í²v¤Î¦Û°ÊÀË¥X²v
The Incidence and Prediction of Automatically Detected
Intraoperative Cardiovascular Events in Noncardiac Surgery
Rainer Röhrig,
Dr. med., Axel Junger, PD Dr. med., MBA (FIT), Bernd Hartmann, Dr. med.,
Joachim Klasen, Dr. med., Lorenzo Quinzio, Dr. med., Andreas Jost, Matthias
Benson, Dr. med. habil., and Gunter Hempelmann, Prof. Dr. med. Dr. h.c. Section
Editor
Anesth Analg 2004;98:569-577
¡@
¦¹¬ã¨s¬O¥X©ó½è¶q«OÃÒªº¥Øªº¨Óµû»ù³N¤¤¦Û°ÊÀË¥X¤ß¦åºÞ¨Æ¥ó(CVE)ªº58¡A458¦W¶i¦æ«D¤ßŦ¤â³N±wªÌªº¹w«á¼Ò«¬¡C§Ų́ϥÎ×q«áªº¤ßŦ¦MÀI«ü¼Æ(RCRI)¥H¤ÎASA¤À¯Å¨Óµû¦ô³Â¾K¦MÀI¡C¥H¦¹§Ú̫إߤF¨âºØ·sªº¼Ò«¬¡C³q¹L¹q¤l³Â¾K«ùÄò°O¿ý¨t²Î¨Óµo²{CVEs¡C¨Ï¥ÎÅÞ¿è¦^Âk¨Ó«Ø¥ß¤@Ó½ÆÂø©M¤@Ó²³æªº¼Ò«¬¡C¨Ï¥Î®Õ·Ç©M¿ë§Oªº¤ÀªR¨Óµû»ù¹w«á¼Ò«¬ªº·Ç½T©Ê¡C¦bµû¦ô(n = 29,437)ªº5249¦W±wªÌ(17.8%)©MÃҹꪺ(n = 29,021) 5031¦W±wªÌ(17.3%)¤¤¦Ü¤Ö¦³¤@¶µCVE¡CCVE©MÂå°|¯f¦º²vÅãµÛ¬ÛÃö(2.1%
¤ñ 1.0%; P < 0.01)¡C·sªº¼Ò«¬Åã¥Ü¤F«Ü¦nªº¿ë§O¤O¡A¨ü¸ÕªÌ¤u§@¯S¼x¦±½u(AUC)¤U±¿n¤À§O¬°0.709
©M 0.707¡C¦ÓASA¤ÀÃþ(AUC
0.647)©M RCRI (AUC 0.620)ªº¸ÑªR«×®t¤@¨Ç¡C¦ý¬O¨âºØ·sªº¼Ò«¬©MASA
¡ARCRIªº¿ë§O²v³£ÁÙ¤£°÷¡C³æ¯ÂªºASA¤À¯Å©M RCRI³£¤£¾A¦X¥Î©ó¹w¨£³N¤¤CVEªºµo¥Í¡C
¡]¤èªÚ Ķ Á§±iºõ ®Õ¡^
The objective of this study was to evaluate prognostic models for quality assurance purposes in predicting automatically detected intraoperative cardiovascular events (CVE) in 58,458 patients undergoing noncardiac surgery. To this end, we assessed the performance of two established models for risk assessment in anesthesia, the Revised Cardiac Risk Index (RCRI) and the ASA physical status classification. We then developed two new models. CVEs were detected from the database of an electronic anesthesia record-keeping system. Logistic regression was used to build a complex and a simple predictive model. Performance of the prognostic models was assessed using analysis of discrimination and calibration. In 5249 patients (17.8%) of the evaluation (n = 29,437) and 5031 patients (17.3%) of the validation cohorts (n = 29,021), a minimum of one CVE was detected. CVEs were associated with significantly more frequent hospital mortality (2.1% versus 1.0%; P < 0.01). The new models demonstrated good discriminative power, with an area under the receiver operating characteristic curve (AUC) of 0.709 and 0.707 respectively. Discrimination of the ASA classification (AUC 0.647) and the RCRI (AUC 0.620) were less. Neither the two new models nor ASA classification nor the RCRI showed acceptable calibration. ASA classification and the RCRI alone both proved unsuitable for the prediction of intraoperative CVEs.
ÀR¯ß¨Ï¥Î²m¤þ©K¤T嗪ªvÀø³æªÍ³q®ðªº§C®ñ¦å¯g
Nicolas Dalibon,
MD, Marc Moutafis, MD, Ngai Liu, MD, Jean-Dominique Law-Koune, MD,
Stéphanie Monsel, MD, and Marc Fischler, MD
From the Department of Anesthesiology, Hôpital Foch, Université Paris-Ouest, Suresnes, France
Anesth Analg 2004;98:590-594
§Ų́ϥγoÓÀH¾÷Âùª¼ªº«e¤©Ê¬ã¨s¨Óµû»ùÀR¯ß¨Ï¥Î²m¤þ©K¤T嗪¨ÓªvÀø³æªÍ³q®ð(OLV) ®Éªº§C®ñ¦å¯gªº®ÄªG¡C28¦W±wªÌ¨Ï¥Î²§¤þ×ô¡AµÎªâ¤Ó¥§¡Aªü¦±®w¦w¡A¨Ï¥ÎÂùµÄºÞ¶i¦æªÍ¹jÂ÷³N¡C¨Ï¥Î¹¹D¶WÁn±´ÀY¨Óµû»ù¤ßŦ«ü¼Æ¡COLV ´Á¶¡SpO2¡@ µ¥©ó©Î¤p©ó95%¡]§l¤J®ñ0.6¡^ªº±wªÌ³Q¯Ç¤J¥»¬ã¨s¡C¨Ï¥Î¦w¼¢¾¯¡A²m¤þ©K¤T嗪 (12
µg ¡E kg-1 ¡E min-1 «ùÄò10
min ±µµÛ 4 µg ¡E kg-1 ¡E min-1)ª½¨ì SpO2 ¹F¨ì90%©Î§C©ó90%¡]±Æ°£¦b¬ã¨s¤§¥~¡^¡C28¦W±wªÌ¤¤18¤H³Q¯Ç¤J¬ã¨s½d³ò¡A¨ä¤¤9¤H±µ¨ü²m¤þ©K¤T嗪¡A8¤H±µ¨ü¦w¼¢¾¯ªvÀø¡C²m¤þ©K¤T嗪²Õ¤¤¦³¤@Ó¡A¦w¼¢¾¯²Õ¤¤¦³6¤H²×¤îªvÀø(P < 0.05)¡C²m¤þ©K¤T嗪²Õ¤¤8¤H¡A¦w¼¢¾¯²Õ¤¤1¤HªvÀø¦³®Ä(SpO2
«O«ù
95%
¦b OLV´Á¶¡) (P < 0.01)¡C¬ã¨s¤¤¤ß²v¡A°Ê¯ßÀ£¡A¤ßŦ«ü¼Æ³£¨S¦³©úÅã§ïÅÜ¡C¦ý¬O§ÚÌ¥u¦b¤@¥bªº±wªÌ¤¤µo²{¨¬°÷ªº¥D°Ê¯ß¦å¬y¡C²m¤þ©K¤T嗪¥i¥H¥Î¨ÓªvÀø³æªÍ³q®ð®Éªº§C®ñ¦å¯g¡C
¡]¤èªÚ Ķ Á§±iºõ ®Õ¡^
We performed this prospective randomized double-blinded study to assess the ability of almitrine to treat hypoxemia during one-lung ventilation (OLV). Twenty-
eight patients were anesthetized with propofol,
sufentanil, and atracurium; lung separation was achieved with a
double-lumen tube. A transesophageal Doppler probe was inserted to
evaluate cardiac index. If SpO2 was equal to or decreased
to <95% during OLV (inspired fraction of oxygen of 0.6), patients
were included in the study and received a placebo or almit- rine (12
µg ¡E kg-1 ¡E min-1 for 10 min followed by
4 µg ¡E kg-1 ¡E min-1) infusion until SpO2
reached 90% or decreased to <90% (exclusion from the study).
Eighteen of the 28 patients were included and received either
almitrine (n = 9) or a placebo (n = 9). Treatment was discontinued in 1 patient in the
almitrine group and 6 in the placebo group (P < 0.05). Treatment was successful (SpO2
remaining
95%
during OLV) in 8 patients in the almitrine group and 1 in the
placebo group (P <
0.01). Heart rate, arterial blood pressure, and cardiac index did
not change throughout the study, but we could obtain an adequate
aortic blood flow signal in only half of the patients. Almitrine
could be used to treat hypoxemia during OLV.
Frederick A.
Robertson, MD, and George M. Hoffman, MD Section Editor
From the Department of Pediatric Anesthesiology, Children¡¦s Hospital of Wisconsin, and the Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin
Anesth Analg 2004;98:617-622
¡@
¯ß·i¦å®ñp»s³y°Ó¤¶²Ð¤F§Þ³N¡AÁnºÙ¥i¥H´£°ª§C®ñªºÀË¥X²v¡C¥Ñ©ó´£°ª«H¸¹ªº³B²z©M¸ê®Æªººtºâªk¹ï³Ì²×¸ê®Æ¦³¤£¦Pªº§@¥Î¡A§Ṳ́ñ¸û¤F¦b¤£¦Pªº«H¸¹¾ã¦X©M¦å®ñ¹¡©M«×¤UNellcor N-395, Masimo SET®, and GE
Solar 8000¦å®ñpªº¸ê®Æ³ø§i¡A«H¸¹±Òµo©M¨ó©w¡C¦b27¦ì±wªÌ¤¤¤@¹ï¤@¶i¦æ§Þ³N¤ñ¸û¡A¤ÀªR®É¶¡©M¸ê®ÆªºÃö«Y¡AÀË´ú¨ó©w©M«H¸¹±Òµo¡A³q¹L«H¸¹¾ã¦X©M
SpO2¨Ó¶i¦æ³øÄµ¤À¼h¡CSolar 8000¤ñ¨ä¥L¨âÓ·sªº¾÷¾¹§ó¤Ö¦³¸ê®Æ°k²æ¡CMasimo¡¦s
LoSIQ¡]«H¸¹½è¶q¡^±Òµo¤ñNellcor¡¦s MOT/PS¡]¹B°Ê/¯ß·iÀË´ú¡^¤ÏÀ³¤F§ó¤Öªº¸ê®Æ¡C·í¨S¦³«H¸¹±Òµo³QÅã¥Üªº®ÉÔ¡A¨âªÌ¤§¶¡¦bºë½T©Ê©M°¾®t¤è±¨S¦³®t§O¡CµM¦Ó¡A¨âºØ»ö¾¹¤§¶¡ªº¨ó©w¦bSIQ,
MOT, ©Î§C®ñ¦å¯gªº±¡ªp¤U·|´c¤Æ¡C¨âºØ»ö¾¹³£¥i¥H°I´î¦³°ÝÃDªº«H¸¹¡A¦ý¬O¥L̤£¦Pªººtºâªk³y¦¨¤F¤£¦Pªºµ²ªG¡C¦]¦¹¡A¦b§CSIQ©M§C®ñ¤UNellcor N-395 ©M Masimo¦å®ñ»ö¦bÁ{§É¤W¬O¤£¦Pªº¡A©M¦ÑªºGE Solar 8000¦å®ñp¤]¤£¦P¡C
¡]¤èªÚ Ķ Á§±iºõ ®Õ¡^
Pulse oximetry manufacturers have introduced technologies that claim improved detection of hypoxemic events. Because improvements in signal processing and data rejection algorithms may differentially affect data reporting, we compared the data reporting and signal heuristic performance and agreement among the Nellcor N-395, Masimo SET®, and GE Solar 8000 oximeters under a spectrum of conditions of signal integrity and arterial oxygen saturations. A blinded side-by-side comparison of technologies was performed in 27 patients, and data were analyzed for time of data availability, measures of agreement and signal heuristics, and warnings stratified by signal integrity and SpO2. The Solar 8000 had less total data dropout than either of the new technologies. Masimo¡¦s LoSIQ (signal quality) heuristic rejected less data than Nellcor¡¦s MOT/PS (motion/pulse search) flag. When no signal heuristic was displayed, there was little difference in precision and bias between the two newer technologies; however, agreement between devices deteriorated in the presence of SIQ, MOT, or hypoxemia. Both newer devices flagged questionable data, but their use of different rejection algorithms resulted in different probabilities of presenting data. Therefore, with poor SIQ or during hypoxemia, the Nellcor N-395 and Masimo oximeters are not clinically equivalent to each other or to the older Solar 8000 oximeter
¦æ¨«®É¶¡¹ï§Q¦h¥d¦]¯á³Â«á¤@¹L©Ê¯«¸g¯gª¬µo¥Íªº¼vÅT
The Influence of Ambulation Time on the Incidence of
Transient Neurologic Symptoms After Lidocaine Spinal Anesthesia
Martti Silvanto, MD*,
Pekka Tarkkila, MD, PhD
, Marja-Leena Mäkelä, MD
, and Per H. Rosenberg, MD, PhD
Research Institute of Military Medicine and
Department
of Anaesthesia, Central Military Hospital, Helsinki;
Department
of Anesthesiology and Intensive Care Medicine, Helsinki University Hospital
Anesth Analg 2004;98:642-646
§Q¦h¥d¦]¯á³Â«á¤@¹L©Ê¯«¸gºî¦X¯g¡]TNS¡^©|¤£²M·¡¡C¤w¦³ªº°²³]»{¬°¯á³Â«á¦´Á¦æ¨«¥i¯à¾ÉPTNSªºµo®i¡C§Ṵ́²³]2¢Hµ¥¤ñ«ªº§Q¦h¥d¦]50mg¥Î©ó½¥Ãö¸`Ãè¤â³N«á¡A¦æ¨«®É¶¡¯àTNSªºµo¥Í¡C120¦ì¦æ½¥Ãö¸`Ãè¤â³N¡]ASA¤À¯Å1~2¡^ªº¯f¤H³QÀH¾÷¤À¦¨3²Õ¡A¦p¦´Á¦æ¨«²Õ¡]GroupE¡^¡A6¤p®É«á¦æ¨«²Õ¡]Group6¡Ðh¡^©M±ß´Á¦æ¨«²Õ¡]GroupL¡^¡C¦bGroupE¡A¯f¤H³Q¤¹³\¦b¯á³Â«ì´_«á¾¨¦¦æ¨«¡]¥§¡229+/-21¤ÀÄÁ¡A½d³ò135¡Ð247¤ÀÄÁ¡^¡C¦bGroup6¡Ðh¡A¯f¤H¦b¯á³Â«áª×§É¤j¬ù6®ø¥¢¡A¦Ó¦bGroupL¯f¤Hª×§É¦Ü²Ä¤G¤Ñ¦¤W¡C©Ò¦³¯f¤H¦b²Îp¾Ç¡B³Â¾K©M¥~¬ì¾Çªº«ü¼Ð§¡Ãþ¦ü¡CÁ`ªºTNSµo¥Í²v¬°16¢H¡C¨ä¤¤GroupE¦³3¨Ò¡]7.5¢H¡^¡AGroup6¡Ðh¦³11¨Ò¡]28¢H¡^¡AGroupL¦³5¨Ò¡]13¢H¡^¡C¦b¦³©ÎµLTNSªº¯f¤H¶¡¥¼µo²{©úÅã®t²§¡C2¢H§Q¦h¥d¦]50mg¯á³Â«á¦´Á¦æ¨«¨Ã«DTNSªº¦MÀI¦]¯À¡C
¡]Áé»ï Ķ Á§±iºõ ®Õ¡^
The cause of transient neurologic symptoms (TNSs) after lidocaine spinal anesthesia remains unclear. It has been proposed that early ambulation after spinal anesthesia contributes to the development of TNSs. We evaluated the influence of ambulation time on the occurrence of TNSs after spinal anesthesia with 50 mg of 2% plain lidocaine for knee arthroscopy. One-hundred-twenty patients undergoing knee arthroscopy (ASA physical status 1¡V2) were randomized into 3 groups, i.e., early (Group E), 6-h (Group 6-h), or late ambulation (Group L) groups. In Group E, ambulation was allowed as early as possible after regression of spinal block (on average 229 ¡Ó 21 min; range, 135¡V247 min). In Group 6-h, the patients remained in bed for approximately 6 h after the block and in Group L until the next morning. The patient groups were comparable with respect to demographic, anesthetic, and surgical variables. The overall incidence of TNSs was 16%. TNSs occurred in 3 patients of Group E (7.5%), in 11 patients of Group 6-h (28%), and in 5 patients of Group L (13%). No significant differences were detected between the patients with and without TNSs. Early ambulation was not found to be a risk factor for TNSs after spinal anesthesia with 50 mg of 2% lidocaine.
¤v¾J¹ï²§¤T»EÅéG³J¥Õ½è
G
i¨È°òªº¼vÅT
The Effects of Hexanol on G
i
Subunits of Heterotrimeric G Proteins
John Streiff, PhD*,
David O. Warner, MD*, Elena Klimtchuk, PhD
, William J. Perkins, MD*, Kristofer
Jones, BS
, and Keith A. Jones, MD*
Departments of *Anesthesiology and
Physiology
and Biophysics,
Mayo
Clinic and Mayo Foundation, Rochester, Minnesota
Anesth Analg 2004;98:660-7
¤A¾J©M¨ä¥L³Â¾KÃįà¤zÂZ¥Ñ¤TÁC»Ä³¾áIËï¡]GTP¡^µ²¦X³J¥Õ¡]G³J¥Õ¡^½Õ¸`ªº¤@¨t¦C¨t²Îªº¥\¯à¡C§ÚÌÀËÅç¤F¤v¾J¹ï²§¤T»EÅéG³J¥Õ½è G
i¨È°ò¬¡©Êªº§@¥Î¡CGTP¤ô¸Ñ¦Aµ²¦XG
I¬¡©Ê¬O0.029¼¯º¸*Pi/¼¯º¸G
I*min¡A³Q¤v¾J¦b¤j©ó10mM¡B¥§¡¬°22mMªº¿@«×©Ò§í¨î¡C¶ê§Î¤G¦â©Ê¥úÃЪk´¦¥Ü¤F¤v¾J±NG
IªºÅܩʷūױq47.2oC°¨ì42.5oC¡A¦Ó¦b10oC¤£§ïÅܨä¤G¯Åµ²ºc¡C³q¹L¤Ø¤o¡Ð±Æ°£ªº®M¦âª©ªkÀËÅç±o¥X¤v¾J¡]30mM¡^¯à°§C¤ô·»²G¤¤G
I³æ»EÅ骺¼Æ¶q¡A³o´£¥Ü¤F¤v¾J¾ÉP¤F³J¥Õªº»E¦X¡CµM¦Ó¡AGTPµ²¦X¨ì±q®ð¹D¥·Æ¦Ù½¤§K¬Ì¨I¾ý¦Ó±oG
Iªº³t«×¨Ã¤£³Q¤v¾J¡]30mM¡^©Ò¼vÅT¡C°£¥~¥Ñ»E¦X»¤¾Éªº°²¹³²£¥Íªº¦Aµ²¦XG
Iªº©úÅã§í¨î¡A§Ų́èS¦³µo²{¦b§¹¾ãªº®ð¹D¥·Æ¦Ù¡A¥Ñ©ó¤º·½©Ê[35S]GTP
Sµ²¦X¨ìG
I³t«×ªºª½±µ§í¨î¦Ó¾ÉPªº¤v¾J»¤¾Éªº¨üÅé±Ò°ÊªºG
I½¢Áp³~®|ªº§í¨î¡C
¡]Áé»ï Ķ Á§±iºõ ®Õ¡^
Alcohols and other anesthetics interfere with the function
of a variety of systems regulated by guanosine triphosphate
(GTP)-binding proteins (G proteins). We examined the effect of
hexanol on the activity of the
subunit
(G
i1)
of heterotrimeric G proteins. The GTP hydrolysis activity of
recombinant G
i1
was 0.029 mole Pi ¡E mole G
i1-1
¡E min-1 and was inhibited by hexanol at concentrations
larger than 10 mM, with a 50% inhibitory concentration of 22 mM.
Circular dichroism spectroscopy revealed that hexanol decreased the
denaturation temperature of G
i1
from 47.2¢XC to 42.5¢XC without altering its secondary structure at
10¢XC. Hexanol (30 mM) reduced the amount of monomeric G
i1
in solution measured by size-exclusion chromatography, indicating
that hexanol caused protein aggregation. However, the rate of GTP
S
binding to G
i
immunoprecipitated from airway smooth muscle membranes was not
affected by 30 mM hexanol. Excluding the apparent inhibition of
recombinant G
i1
resulting from aggregation-induced artifact, we found no evidence
that the hexanol-induced inhibition of receptor-activated G
i-coupled
pathways in intact airway smooth muscle resulted from direct
inhibition of the intrinsic rate of [35S]GTP
S
binding to G
i.
¦åºÞÂX±i´£°ª¤j¹«¥¬¤ñ¥d¦]»¤µoÅå³Öªº°ìÈ
Vasodilation Increases the Threshold for
Bupivacaine-Induced Convulsions in Rats
Yutaka Oda, MD PhD,
Tomoharu Funao, MD, Katsuaki Tanaka, MD, and Akira Asada, MD PhD
From the Department of
Anesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka
City University, Osaka, Japan
Anesth Analg 2004 98: 677-682
¥¬¤ñ¥d¦]³q¹L¥~©P©M¤¤¼Ï¯«¸g¨t²Îªº¾÷¨î¼vÅT¤F¦åºÞªý¤O¡C¦]¬°¦åºÞ¦¬ÁYÃļW¥[¤FÀR¯ßª`®g¥¬¤ñ¥d¦]ªº¤¤¼Ï¯«¸g¨t²Î¬r©Ê¡A¬G¦åºÞÂX±iÃÄ¥i¯à°§C³oºØ¬r©Ê¡C§ÚÌÀËÅç¤F¸Ó°²³]¡A§Y¦åºÞÂX±iÃݧC¤F²M¿ô¡B¦Û¥D©I§lªº¦Ñ¹«¤¤¥¬¤ñ¥d¦]ªº¤¤¼Ï¬r©Ê¡C¶¯©ÊSprague-Dawley¦Ñ¹«³QÀH¾÷¤À¦¨¹ï·Ó²Õ¡]C¡^¡B¥§¥d¦a¥²Õ¡]N¡^©M×ô§´©Ô©ú²Õ¡]P¡^¡]¨C²Õ12¨Ò¡^¡C¥H1mg/kg/minªº³t«×µ¹¤©®ø±Û¥¬¤ñ¥d¦]ª½¦Ü¥X²{ºò±i/°}ÅË©ÊÅå³Ö¡C3²ÕÀH¥¬¤ñ¥d¦]¦P®É¤À§Oµ¹¤©¥Í²zÆQ¤ô¡B¥§¥d¦a¥¡]0.4ug/min¡^©M×ô§´©Ô©ú¡]³Ìªì5¤ÀÄÁ10ug/min¡AÀH«á50ug/min¡^¡CC²Õª`®g¥¬¤ñ¥d¦]«á¥§¡°Ê¯ßÀ£©úÅã¤É°ª¦ÓN²Õ¡BP²Õ¦bÅå³Öµo§@«eºû«ù¦b°ò½u¤ô¥¡CC²Õ¥¬¤ñ¥d¦]ªºÅå³Ö¾¯¶q¬°5.8+/-1.5mg/kg¡A¦Ó¦bN²Õ©MP²ÕÅãµÛ¤É°ª¡]¤À§O¬°7.6+/-1.5mg/kg,p=0.02©M8.1+/-1.1mg/kg¡^¡CµM¦Ó¡A¦b3²Õ¤¤µo§@Åå³Ö®É¦å¼ß¤¤Á`ªº©Î«D³J¥Õµ²¦Xªº¥¬¤ñ¥d¦]¿@«×©Î¸£¤º¥¬¤ñ¥d¦]¿@«×¨S¦³®t²§¡C§Ú̱o¥Xµ²½×¡A¥§¥d¦a¥©M×ô§´©Ô©ú´£°ª¤F¥¬¤ñ¥d¦]ªº²Ö¿n¾¯¶q¡A¦ý¨Ã¤£¼vÅT¥Ñ¥¬¤ñ¥d¦]»¤¾ÉªºÅå³Ö©Ò»Ýªº¦å¼ß©Î¸£¤ºªº°ì¿@«×¡C
¡]Áé»ï Ķ Á§±iºõ ®Õ¡^
Bupivacaine affects the vascular resistance by peripheral and central nervous system (CNS) mechanisms. As vasoconstrictors increase the CNS toxicity of IV bupivacaine, vasodilators may decrease its CNS toxicity. We examined the hypothesis that vasodilators decrease the CNS toxicity of bupivacaine in awake, spontaneously breathing rats. Male Sprague-Dawley rats were randomly divided into control (C), nicardipine (N), and phentolamine (P) groups (n = 12 in each group). Racemic bupivacaine was administered IV at 1 mg/kg/min until tonic/clonic convulsions occurred. Saline, nicardipine (0.4 µg/min), and phentolamine (10 µg/min within 5 min, 50 µg/min thereafter) were simultaneously administered with bupivacaine in groups C, N, and P, respectively. Mean arterial blood pressure was significantly increased by infusion of bupivacaine in group C and was maintained at baseline levels before the onset of convulsions in groups N and P. The convulsive dose of bupivacaine in group C was 5.8 ¡Ó 1.5 mg/kg, but was significantly larger in groups N and P (7.6 ¡Ó 1.5 and 8.1 ¡Ó 1.1 mg/kg, P = 0.02 and 0.001, respectively). However, there were no differences in total or protein-unbound plasma concentration of bupivacaine or in concentration of bupivacaine in the brain at the onset of convulsions among the 3 groups. We conclude that nicardipine and phentolamine increase the cumulative dose but do not affect the threshold plasma or brain concentrations required for bupivacaine-induced convulsions.
¤þªyªâ³Â¾K¤¤À³¥Î¸£¹q¹ÏºÊ´ú³Â¾KÃĪ«§@¥ÎªºNarcotrend«ü¼Æ»PÂùÀW«ü¼Æ¤ñ¸û
Narcotrend Index Versus Bispectral Index as
Electroencephalogram Measures of Anesthetic Drug Effect During Propofol
Anesthesia
Sascha Kreuer, MD*, Wolfram Wilhelm, MD DEAA*,
Ulrich Grundmann, MD*, Reinhard Larsen, MD*, and
Jörgen Bruhn, MD
Section Editor
*Department of Anesthesiology and Intensive Care Medicine,
University of Saarland, Homburg/Saar, Germany, and the
Department
of Anesthesiology and Intensive Care Medicine, University of Bonn, Bonn,
Germany
Anesth Analg 2004 98: 692-697
NarcotrendºÊ´ú»ö(MonitorTechnik,
Bad Bramstedt, Germany)¯à°ò©óªì©lEEGªºµøÄ±µû¦ô¹ï³Â¾K´Á¶¡ªºEEG¶i¦æ¦Û°Ê¤ÀªR¡C¥¦ªº³Ì·s³nÅé4.0ª©¥]¬Adimensionless«ü¼Æ¡]Ãþ¦ü©óBIS«ü¼Æ¡^¡A½d³ò±q100¡]Ĭ¿ô¡^¦Ü0¡C§Ṳ́ñ¸û¦b¤þªyªâ³Â¾K¤¤À³¥ÎNarcotrend«ü¼Æ¤ÎBISºÊ´ú³Â¾KÃĪ«§@¥Î¡C¿ï¨ú18¦ì¦æ¾Ü´Á®Úªv©Ê«e¦C¸¢¤Á°£³Nªº¯f¤H¡C³N«e©ó¸y´Õ¶¡»Ø©ñ¸mµw½¤¥~¾ÉºÞ¡A¨Ã«ö¥Í²£°Óªº±ÀÂ˦ì¸m©ñ¸mBIS(version
XP; Aspect Medical Systems, Natick, MA)¤ÎNarcotrendªº¹q·¥¡C¨C5s°O¿ý¤@¦¸Narcotrend«ü¼Æ¡BBISÈ¡B¤þªyªâªº¦å¼ß¿@«×¤Î®ÄÀ³«Ç¿@«×¡C¥Hªâ¤Ó¥§¤Î¤þªyªâ»¤¾É¡A®ðºÞ´¡ºÞ«áµw½¤¥~¤©0.5%¥¬¤ñ¥d¦]15ml¡A45min«á¤þªyªâ¾¯¶q¨Ì¦¸¼W¥[¡B´î¤Ö2¦¸¡C¦b¦¹ºØ¾¯¶q½Õ¾ã¤¤¡A¤þªyªâ®ÄÀ³«Ç¿@«×¦b2.0 ¡Ó 0.4 µg/mL (³Ì§C)
¨ì 6.3 ¡Ó 1.3 µg/mL (³Ì°ª)¤§¶¡ªi°Ê¡C¥ÎNarcotrend«ü¼Æ¤ÎBIS¨Ó¹w´ú¤þªyªâ®ÄÀ³«Ç¿@«×¡]¥HPKªí¥Ü¡^¡A¨âªÌ¤À§O¬°0.88¡Ó0.03,
0.85¡Ó0.04¡C¥ÎNarcotrend«ü¼Æ¤ÎBISºÊ´úÃĪ«§@¥Î¡A¥§¡ke0¤À§O¬°0.20¡Ó0.05
min-1 ¡]Narcotrend«ü¼Æ¡^¡B0.16¡Ó0.07 min-1¡]BIS¡^.¦b¤þªyªâªºªi°Ê½d³ò¤º¡ANarcotrend«ü¼Æ¤ÎBIS§¡¯àÀË´ú¨ìEEGªº°ÊºAÅܤơC
¡]©P¾å±ÓĶ Á§±iºõ ®Õ¡^
The Narcotrend monitor (MonitorTechnik, Bad Bramstedt, Germany) performs an automatic analysis of the electroencephalogram (EEG) during anesthesia based on a visual assessment of the raw EEG. Its newest software version 4.0 includes a dimensionless index that, similar to the bispectral index (BIS), ranges from 100 (awake) to 0. We compared the performance of Narcotrend index and BIS as EEG measures of anesthetic drug effect during propofol anesthesia. Eighteen adult patients scheduled for radical prostatectomy were investigated. An epidural catheter was placed in the lumbar space and electrodes for BIS (version XP; Aspect Medical Systems, Natick, MA) and Narcotrend were positioned as recommended by the manufacturers. Narcotrend index, BIS values, and propofol plasma and effect site concentrations as parallelly simulated by Rugloop software (Department of Anesthesia, Ghent University, Belgium) were automatically recorded in intervals of 5 s. Induction of anesthesia consisted of a fentanyl bolus and a propofol infusion. After endotracheal intubation, patients received 15 mL bupivacaine 0.5% epidurally, and 45 min later propofol dosages were subsequently increased and decreased twice. Simulated propofol effect site concentrations ranged from 2.0 ¡Ó 0.4 µg/mL (smallest) to 6.3 ¡Ó 1.3 µg/mL (largest) during these subsequent increases and decreases of propofol. In terms of prediction probability (PK) the performance of the Narcotrend index (PK = 0.88 ¡Ó 0.03) to predict propofol effect site concentrations was comparable to the BIS (PK = 0.85 ¡Ó 0.04). Using the respective EEG index as a measure of drug effect the mean ke0 was calculated as 0.20 ¡Ó 0.05 min-1 for Narcotrend index and 0.16 ¡Ó 0.07 min-1 for BIS. In the observed propofol concentration range Narcotrend index detected differences in EEG dynamics as well as BIS.
´c©Ê°©¸~½F¤Á°£³N¯f¤H¤¤À³¥ÎDextromethorphanÁp¦Xµw½¤¥~PCA¸ûÁp¦XÀR¯ßPCA´£¨Ñ§ó¦nªºÂíµh®ÄªG¡X¡X¤@¶µÀH¾÷¡BÂùª¼¡B¦w¼¢¾¯¹ï·Ó¬ã¨s
Dextromethorphan-Associated Epidural Patient-Controlled
Analgesia Provides Better Pain- and Analgesics-Sparing Effects than
Dextromethorphan-Associated Intravenous Patient-Controlled Analgesia After
Bone-Malignancy Resection: A Randomized, Placebo-Controlled, Double-Blinded
Study
Avi A. Weinbroum, MD*,
,
Benjamin Bender, MD
,
Alexander Nirkin, MD
,
Shoshana Chazan, RN
,
Isaac Meller, MD
,
and Yehuda Kollender, MD![]()
*Postanesthesia Care Unit, the
Acute
Pain Service, and the
National
Orthopedic Oncology Unit, Tel Aviv Sourasky Medical Center and the Sackler
Faculty Medicine, Tel Aviv University, Tel Aviv, Israel
Anesth Analg 2004 98: 714-722.
´c©Ê°©¸~½F¥~¬ì³N«á¯kµh¼@¯P¡A»Ý¥Î¤j¾¯¶qªº³Â¾KÃÄ¡CDextromethorphan¡]DM¡^¡AN-¥Ò°òD-¤Ñ¥V®ò»Ä¨üÅé«ú§Ü¾¯¡A¤w³QÃÒ©ú¨ã¦³±j¤jªºÂíµh®ÄªG¡C´c©Ê°©¸~½F¯f¤H¦b¼Ð·Ç¥þ³Â½Æ¦Xµw½¤¥~³Â¾K¤U¡]À³¥Î©Î¤£¥ÎDM¡^¥~¬ì¤â³N«á¡A§Ú̹ï¨äÀ³¥Îµw½¤¥~PCA(PCEA)©ÎÀR¯ßPCA(IV-PCA)¨Óµû¦ô¨ä§@¥Î¡CÀH¾÷¥l¶°120¦ì¤¸¯f¤H¡A³N«áÀ³¥ÎPCEA(ù¬£¥d¦]3.2mg¡Ïªâ¤Ó¥§8ug/³æ¾¯)©ÎIV-PCA(¶Ü°Ømg/³æ¾¯)¡A§¡¦b¥DÆ[µøÄ±¯kµhµû¤À>=4®É¶}©lÀ³¥Îª½¦Ü³N«á96h¡C¨C²Õ¤¤¦U¨ú30¦ì¯f¤H¤©¦w¼¢¾¯©ÎDM 90mg¤fªA¡]³N«eÀ³¥Îª½¦Ü³N«á2¤Ñ¡^§@¬°Âùª¼¹ï·Ó¡C¯kµh¼@¯P®É¤©Diclofenac75mg
IM§@¬°¸É±Ï¡CÀ³¥ÎDMªº¯f¤HPCA¨Ï¥Î¤Î¯kµhµû¤À¸û¦P²Õ¦w¼¢¾¯¹ï·Ó¯f¤H´î¤Ö50¢H¡A¯S§O¬O³N«á2¤Ñ¤º¡]P<0.01¡^¡CPCEA²Õªº¨C¤p®É¤ÎÁ`¯kµh±j«×§¡¸ûIV-PCA²Õ´î¤p50¢H(P<0.01)¡CPCA-DM¯f¤HªºDiclofenac¥Î¶q¸û¦P²Õ¦w¼¢¾¯¹ï·Ó¯f¤H´î¤Ö42¢H(P<0.01)¡CPCEA-DM²Õ7¤H¡BIV-PCA-DM²Õ11¤H³ø§i¦³°Æ§@¥Î¡A¦ÓPCEA-¦w¼¢¾¯²Õ¤ÎIV-PCA-¦w¼¢¾¯²Õ¦@44¤H³ø§i¦³°Æ§@¥Î(P<0.01)¡CÀ³¥Î¨âºØ¤£¦PÂíµh§Þ³Nªº¯f¤H³Ì¦¤U§É¬¡°Ê®É¶¡¬Ûªñ¡A¦ýÀ³¥ÎDMªº¯f¤H¸û¦w¼¢¾¯²Õ¤U§É®É¶¡µu(1.5+-0.8
VS 2.1+-1.1d¡AP=0.02)¡C¦]¦¹¡ADM¯à¦³®Ä¦a±±¨î¯kµh¨Ã´î¤Ö³Â¾K©ÊÃĪ«¥Î¶q¡A¦¹ºØ¼W±j§@¥Î¦bPCEA²Õ¸ûIV-PCA²Õ§ó©úÅã¡C¦¹¥~À³¥ÎDMªº¯f¤H¤U§É¬¡°Ê®É¶¡¸û¦w¼¢¾¯À³¥ÎªÌ¦¡C
¡]©P¾å±Ó Ķ Á§±iºõ ®Õ¡^
Pain after bone malignancy surgery is intense and requires
large amounts of analgesics. The augmented antinociceptive effects
of dextromethorphan (DM), a N-methyl-D-aspartate
receptor antagonist, were demonstrated previously. We assessed the
use of postoperative patient-controlled epidural analgesia (PCEA) or
IV patient-controlled analgesia (PCA) in patients undergoing surgery
for bone malignancy under standardized combined general and epidural
anesthesia with or without DM. Patients (n = 120) were randomly allocated to receive
PCEA (ropivacaine 3.2 mg plus fentanyl 8 µg/dose) or IV-PCA
(morphine 2 mg/dose) postoperatively, starting at subjective visual
analog scale pain intensity
4
of 10 for up to 96 h. Placebo or DM 90 mg orally (30 patients/group/set)
was given in a double-blinded manner before surgery and for 2
days afterwards. Diclofenac 75 mg IM was available as a rescue drug.
DM patients used PCA and rated their pain >50% less than their
placebo counterparts in each set, especially during the first 2
postoperative days (P < 0.01).
Hourly and overall maximal pain intensity among PCEA patients was
50%
less than in the IV-PCA set (P < 0.01). Diclofenac was used 42% less (P < 0.01) by the PCA-DM patients compared with their
placebo counterparts. Seven PCEA-DM and 11 IV-PCA-DM individuals
reported having side effects compared with 44 in the PCEA-placebo
and the IV-PCA-placebo groups (P < 0.01). Time to first ambulation was
similar with both analgesia techniques but shorter among the
DM-treated patients compared with the placebo recipients (1.5 ¡Ó 0.8
versus 2.1 ¡Ó 1.1 days, P = 0.02).
Thus, DM afforded better pain control and reduced the demand for
analgesics, augmented the PCEA effect versus IV-PCA, and was
associated with minimal untoward effects in each analgesia set. DM
patients ambulated earlier than placebo recipients.
ÀT¤º©Î¤fªA¥i¼Ö©w¹w¨¾³N«á°sºë§ÙÂ_ºî¦X©º¡X¡X¤@¶µÀH¾÷¡BÂùª¼¹ï·Ó¬ã¨s
Intrathecal and Oral Clonidine as Prophylaxis for
Postoperative Alcohol Withdrawal Syndrome: A Randomized Double-Blinded Study
I. Dobrydnjov, MD*, K. Axelsson, MD PhD*,
L. Berggren, MD PhD*, J. Samarütel, MD PhD
,
and B. Holmström, MD PhD*
*Departments of Anesthesiology and Intensive Care,
Örebro University Hospital, Örebro, Sweden; and
Tartu
University Hospital, Tartu, Estonia Anesth Analg 2004 98: 738-744
¦b¦¹¶µ¬ã¨s¤¤¡A§Ú̵û»ù¤F¦b¨ã³N«áµo¥Í°sºë§ÙÂ_ºî¦X¯g(AWS)¦MÀIªº¯á³Â¯f¤H¤¤¸É¥RÀT¤ºÀ³¥Î©Î¤fªA¥i¼Ö©wªº®ÄªG¡C§Ṵ́²©w¥i¼Ö©w¹ï³N«áAWS¦³¹w¨¾§@¥Î¡C45¦ì°sºë¨Ì¿à¯f¤H(¤A¾JÄá¤J>60g/d)¡A¦æ¾Ü´Á¸g§¿¹D«e¦C¸¢¤Á°£³N(TURP)¡AÀH¾÷Âùª¼¤À¬°3²Õ¡C©Ò¦³¯f¤H¤©§Q¦h¥d¦]100mg°ª¤ñ«²Gµïºô½¤¤UµÄª`®g¡C¦a¦èÌñ²Õ(DiazG)¤©³N«e¦a¦èÌñ10mg¤fªA¡AÀT¤º¥i¼Ö©w²Õ(Cloni/tG)¤©¤fªA¦w¼¢¾¯¨ÃÀT¤ºÀ³¥Î¥i¼Ö©w150ug¡A¤fªA¥i¼Ö©w²Õ(Clonp/oG)¤©¥i¼Ö©w150ug¤fªA¡C«ö°sºë§ÙÂ_Á{§Éµû¦ô©eû·|¨î©wªºµû¤À¼Ð·Ç¶EÂ_AWS¯f¤H¡CDiazG²Õ12¦ì¯f¤H¥X²{§ÙÂ_¯gª¬¡A¦ÓCloni/tG²Õ2¦ì¡BClonp/oG²Õ1¦ì¯f¤H¥X²{¯gª¬¡C«ö°sºë§ÙÂ_Á{§Éµû¦ô©eû·|¨î©wªºµû¤À¼Ð·Ç¶i¦æµû¤À¡ADiazG²Õ¥§¡12¤À¦Ó¥i¼Ö©w²Õ¥§¡1¤À¡CDiazG²Õ¦³2¦ì¯f¤H¥X²{ÄY«Ä¸¦k¡CClonp/oG²Õ¯f¤H¯á³Â«á6¡Ð12h¥§¡°Ê¯ßÀ£»´«×¤U°(P<0.05),
DiazG²Õ¯f¤H³N«á24¡Ð72h¥X²{°ª°Ê¤O©Ê°j°é¤ÏÀ³¡CÁ`¤§¡A³N«eÀT¤ºÀ³¥Î©Î¤fªA¥i¼Ö©w150ug¥i¹w¨¾°sºë¨Ì¿à¯f¤Hµo¥ÍÄY«³N«áAWS¡C
¡]©P¾å±ÓĶ Á§±iºõ ®Õ¡^
¡@In this study, we evaluated the effect of intrathecal and oral clonidine as supplements to spinal anesthesia with lidocaine in patients at risk of postoperative alcohol withdrawal syndrome (AWS). We hypothesized that clonidine would have a prophylactic effect on postoperative AWS. Forty-five alcohol-dependent patients (daily ethanol intake >60 g) scheduled for transurethral resection of the prostate were double-blindly randomized into three groups. All patients received hyperbaric lidocaine 100 mg intrathecally. The diazepam group (DiazG) was premedicated with diazepam 10 mg orally; the intrathecal clonidine group (Cloni/tG) received a placebo (saline) tablet and clonidine 150 µg intrathecally; and the oral clonidine group (Clonp/oG) received clonidine 150 µg orally. For patients diagnosed with AWS, the Clinical Institute Withdrawal Assessment for Alcohol, revised scale, was used. Twelve patients in the DiazG had symptoms of AWS, compared with two in the Cloni/tG and one in the Clonp/oG. The median Clinical Institute Withdrawal Assessment for Alcohol, revised scale, score was 12 in the DiazG versus 1 in the clonidine-treated groups. Two patients in the DiazG had severe delirium. Patients receiving oral clonidine had a slightly decreased mean arterial blood pressure 6¡V12 h after spinal anesthesia (P < 0.05); patients in the DiazG had a hyperdynamic circulatory reaction 24¡V72 h after surgery. In conclusion, preoperative clonidine 150 µg, intrathecally or orally, prevented significant postoperative AWS in ethanol-dependent patients.
Anesth Analg 2004 98: 738-744
²§¬tîŹ什¨_©Ê¸£¯Ê¦å¤j¹«¯«¸g¤¸ä¤`ªº¼vÅT
Effect of isoflurane on neuronal apoptosis in rats
subjected to focal cerebral ischemia.
Kawaguchi M, Drummond JC, Cole DJ, Kelly PJ, Spurlock MP, Patel PM.
Department of Anesthesiology, VA Medical Center and University of California, San Diego, California, USA.
Anesth Analg 2004 98¡G 798-805
ÁöµM²§¬tîÅ¥i¥H´î¤Öµu¼È¯Ê¦å«á«ì´_´Áªº¯Ê¦å©Ê¯«¸g¤¸·l¶Ë¡A¦ý¬O³o¤@¸£«OÅ@®Ä¤O¨Ã«D¬O«ùÄò¤£Åܪº¡C¯«¸g¤¸ªºä¤`¥iÂk¦]©ó¯Ê¦å«á±ð¶ë±¿nªº³v¨BÂX¤j¡C³o´£¥Ü¾¨ºÞ²§¬tîÅ¥i´î¤Ö¦´Á¯«¸g¤¸ªº¦º¤`¡A¦ý¥i¯àµLªk§í¨î¯Ê¦å¤Þ°_ªº¯«¸g¤¸ä¤`¡C§Ú̬ã¨s¤F²§¬tîŹ什¨_©Ê¯Ê¦å¤j¹«ªº¼Ð°O²ÓMä¤`ªº¼vÅT¡C¨Ï¥Î²§¬tîų¾KWistar-Kyoto¤j¹«¨ÃÀH¾÷¤À¬°²M¿ô²Õ(n = 40)©M²§¬tîŲÕ(n = 40)¡A¨â²Õ¤j¹«§¡³q¹Lµ²²Ï¤j¸£¤¤°Ê¯ß70¤ÀÄÁ¨Ó§Î¦¨§½¨_©Ê¯Ê¦å¡C¹êÅç¹Lµ{¤¤ÀY³¡·Å«×±±¨î¦b37+/- 0.2¢J¡C¦b²M¿ô²Õ²§¬tî۱¤î¨Ï¥Î¡A¤j¹«¥iĬ¿ô;¦b²§¬tîŲաA²§¬tîų¾Kºû«ù¦b1.5 MAC¡C¤j¹«¦b¦AÄéª`«á²Ä7¤p®É¡B²Ä1¡B²Ä4©Î²Ä7¤Ñ³B¦º¡]n=10/²Õ/®ÉÂI¡^¡C¸£±ð¶ë±¿n³q¹LĬ¬õ¬V¦â¤Á¤ùªº¹Ï¹³¤ÀªR¨Ó¶i¦æpºâ¡C¦b¤TÓ¬Û¾F¤Á¤ù¤¤¡A³q¹LTUNEL¬V¦â©M§K¬Ì¬V¦âªkÃÒ¹ê¤Fä¤`²ÓM¤¤¦³¬¡©Êªºcaspase-9©Mcaspase-3¡C¦AÄéª`«á7¤p®É¡B1¤Ñ©M4¤Ñ²§¬tîŲժº±ð¶ë±¿n¤p©ó²M¿ô²Õ(P < 0.05)¡AµM¦Ó¦AÄéª`«á7¤Ñ¨â²Õ¨ÃµL®t§O¡C¯Ê¦å1¤Ñ«á²M¿ô²Õªºä¤`²ÓM(TUNEL,
caspase-3, ©M caspase-9 ¶§©Ê)¼Æ¶q©úÅã¦h©ó²§¬tîŲաA¸g¹L4¤Ñ©Î7¤Ñªº«ì´_´Á¡A²§¬tîŲժºä¤`²ÓM¦h©ó²M¿ô²Õ¡C7¤Ñ«á¡Acaspase-3 ©M -9¶§©Êªº¯«¸g¤¸¼Æ¶q¦b²§¬tîŲդ¤¸û¦h(P
< 0.05)¡C³o¨Ç¸ê®Æªí©ú²§¬tîŬO©µ¿ð¦Ó¤£¬Oªý¤î¤F¯Ê¦å¾ÉPªº¸£±ð¶ëªºµo®i¡C²§¬tîÅ´î¤Ö¤F¯Ê¦å«á¦´Áªºä¤`ªºµo®i¡A¦ý¬O¨Ã¨S¦³ªý¤î¯Ê¦å«á«ì´_«á´Áªºä¤`ªºµo®i¡Cµ²½×¡G§Ú̬ã¨s¤F²§¬tîŹ什¨_©Ê¸£¯Ê¦å¤j¹«ªº¯«¸g¤¸ä¤`ªº¼vÅT¡C¦b²§¬tîų¾Kªº¤j¹«¡A¯Ê¦å¤Þ°_ªºä¤`µo¥Í©ó¯Ê¦å«á«ì´_ªº±ß´Á¶¥¬q¡A²§¬tîŨ䣧í¨î¯Ê¦å«áªº¯«¸g¤¸ä¤`¡C
¡]³°¦°°¶ Ķ Á§±iºõ ®Õ¡^
Although isoflurane can reduce ischemic neuronal injury after short postischemic recovery intervals, this neuroprotective efficacy is not sustained. Neuronal apoptosis can contribute to the gradual increase in infarct size after ischemia. This suggests that isoflurane, although capable of reducing early neuronal death, may not inhibit ischemia-induced apoptosis. We investigated the effects of isoflurane on markers of apoptosis in rats subjected to focal ischemia. Fasted Wistar-Kyoto rats were anesthetized with isoflurane and randomly allocated to awake (n = 40) or isoflurane (n = 40) groups. Animals in both groups were subjected to focal ischemia by filament occlusion of the middle cerebral artery for 70 min. Pericranial temperature was servo-controlled at 37 degrees C +/- 0.2 degrees C throughout the experiment. In the awake group, isoflurane was discontinued and the animals were allowed to awaken. In the isoflurane group, isoflurane anesthesia was maintained at 1.5 MAC (minimum alveolar anesthetic concentration). Animals were killed 7 h, 1 day, 4 days, or 7 days after reperfusion (n = 10/group/time point). The area of cerebral infarction was measured by image analysis in a hematoxylin and eosin stained section. In three adjacent sections, apoptotic neurons were identified by TUNEL staining and immunostaining for active caspase-9 and caspase-3. Infarct size was smaller in the isoflurane group than the awake group 7 h, 1 day, and 4 days after reperfusion (P < 0.05). However, this difference was absent 7 days after reperfusion. The number of apoptotic (TUNEL, caspase-3, and caspase-9 positive) cells 1 day after ischemia was significantly more in the awake versus isoflurane group. After a recovery period of 4 or 7 days, the number of apoptotic cells in the isoflurane group was more than in the awake group. After 7 days, the number of caspase-3 and -9 positive neurons was more in the isoflurane group (P < 0.05). The data indicate that isoflurane delays but does not prevent the development of cerebral infarction caused by ischemia. Isoflurane reduced the development of apoptosis early after ischemia but did not prevent it at later stages of postischemic recovery. IMPLICATIONS: The effect of isoflurane on neuronal apoptosis was investigated in rats subjected to focal cerebral ischemia. In isoflurane-anesthetized animals, ischemia-induced apoptosis occurred during the later stages of postischemic recovery. Isoflurane did not inhibit postischemic neuronal apoptosis.
«ùÄò©Ê骶©P©M§¤°©¯«¸gªýº¢¡G¤@¶µX½u¤ù¬ã¨s
Continuous parasacral sciatic block: a radiographic
study.
Gaertner E, Lascurain P, Venet C, Maschino X, Zamfir A, Lupescu R, Hadzic A.
*Service d¡¦Anesthésie Réanimation Chirurgicale
Hôpital de Hautepierre, Strasbourg, France;
Service
d¡¦Anesthésie, Clinique des Eaux Claires, Grenoble, France; and
Department
of Anesthesiology, St. Luke¡¦s-Roosevelt Hospital, New York, New York
Anesth Analg 2004 98: 831-834.
§¹¥þ©Êªº骶ÂO³Â¾K¾ÉP¤F骶©P©M§¤°©¯«¸gªýº¢¡C¦b³o¶µ¬ã¨s¤¤¡A§ÚÌÆ[¹î¤F¸g骶ºÞª`¤Jªº§½³ÂÃĪºÂX´²ªº¨M©w¦]¯À¡A骶ºÞª`¤JÂIªº¸Ñå¦ì¸m©Mªýº¢ªº½d³ò¤Î±j«×¡C§Ṵ́O¿ý¤F87¦W¥Dn¦æ¤UªÏ¤â³Nªº¯f¤H¡A¸mºÞ«áª`¤J8 mLªº¤£³z®g½uªº¹ï¤ñ¬V®Æ¡A¨Ï¥ÎX½u¤ù¤ÀªRª`¤J²Gªº´²§G±¡ªp¡A¦P®É¶i¦æ·Pı©M¹B°Êªº¤ÀªR¡Cª`¤J²GªºX½u¤ù¤ÀªRÅã¥Ü´X¥G©Ò¦³ªº¾ÉºÞ(86 ®Ú¾ÉºÞ, ¥e99%)³£¦b¥¿½Tªº¸Ñå¦ì¸m¡C§½³ÂÃĪ`¤Jªº¥§¡®e¶q¬°21 +/- 3 mL¡C©Ò¦³¯f¤Hªº骶ÂOªº¥þ³¡¤TÓ¥Dn²Õ¦¨³¡¤À¡]×H¯«¸g¡BµÌÁ`¯«¸g©MªÑ«á¥Ö¯«¸g¡^³£¹F¨ì¤F·Pıªýº¢¡C§Ú̱o¥Xµ²½×¡G骶ÂOªº¥þ³¡¤TÓ¥Dn²Õ¦¨³¡¤Àªº¦¨¥\ªýº¢¾ÉP骶©P©M§¤°©¯«¸gªýº¢¡A¥¦¦³µo¥Í¨Öµo¯gªº·L¤p·ÀI¡C¹ï¤ñ©ÊX½u¤ù¥i¥Î©óÃÒ¹ê¾ÉºÞªº¦ì¸m¡Cµ²½×¡G骶ÂOªº¥þ³¡¤TÓ¥Dn²Õ¦¨³¡¤À¡]×H¯«¸g¡BµÌÁ`¯«¸g©MªÑ«á¥Ö¯«¸g¡^ªº¦¨¥\ªýº¢¾ÉP骶©P©M§¤°©¯«¸gªýº¢¡C¹ï¤ñ©ÊX½u¤ù¥i¥Î©óÃÒ¹ê¾ÉºÞªº¥¿½T¦ì¸m¡C
¡]³°¦°°¶ Ķ Á§±iºõ ®Õ¡^
Parasacral sciatic blockade results in anesthesia of the entire sacral plexus. In this study we sought to determine the spread of the local anesthetic injected through a parasacral catheter, the anatomical location of the inserted catheters, and the extent and reliability of the blockade. In this study, 87 consecutive patients undergoing major lower limb surgery were enrolled. After placement of the catheter and injection of 8 mL of radio-opaque contrast dye, radiographic images were evaluated for dispersion of the injectate. Sensory and motor evaluations were also performed. Radiographic analysis of the injectates revealed that nearly all catheters (86 catheters, 99%) were in the correct anatomical position. The mean volume of local anesthetic injection was 21 +/- 3 mL. All patients developed a full sensory block of all three major components of the sciatic plexus (tibial, common peroneal, and posterior cutaneous nerve of the thigh). We conclude that the parasacral sciatic block results in frequent success of blockade of all three major components of the sciatic plexus and it has a small risk of complications. Contrast radiography can be used to document the catheter placement.
µu´Áµw½¤¥~ªýº¢¹ï¶¡½è©Ê»H¯Öª¢ªº§¿²GPª«½è¤ô¥ªº¼vÅT
The effect of short-term epidural local anesthetic
blockade on urinary levels of substance P in interstitial cystitis.
Sukiennik A, Carr DB, Bonney I, Marchand JE, Wurm H, Sant GR.
Departments of Anesthesia and Urology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
Anesth Analg 2004 98:
846-850.
§Ú̬ã¨s¤Fµw½¤¥~ªýº¢¹ï¤Ó¬ðµo©Ê¯kµhªº¶¡½è©Ê»H¯Öª¢¯f¤Hªº§¿²GPª«½è¤ô¥ªº¼vÅT¡Cµw½¤¥~º¥ý¨Ï¥Î0.25%ªº¥¬¤ñ¥d¦]¡AµM«á¥Î0.05%ªº¥¬¤ñ¥d¦]ºû«ù¡A¦¬¶°24¤p®Éªº§¿²G¡A¨Ï¥Î©ñ®g§K¬Ìªk´ú¶qPª«½è§t¶q¡C¦bµw½¤¥~ª`ÃĶ}©l«á¡A©Ò¦³ªº¯f¤H§¿²G¤¤Pª«½è¤ô¥¥ý¤É°ªµM«á¤U°¡C©Ò¦³ªº¯f¤H¥Dz¯kµhµ{«×´î»´¡C§Ú̦Ҽ{¦b3¤Ñªºµw½¤¥~µ¹ÃÄ´Á¶¡»H¯Ö·Pı¯«¸g¥½±éªºPª«½èªº«æ©ÊÄÀ©ñ©M·l¯Ó¾ÉP§¿²G肽¤ô¥ªºµu¼È¤É°ª©M¯kµh±j«×ªº´î»´¡Cµ²½×¡G¦b5Өϥεw½¤¥~µ¹ÃĹF¨ìÂíµhªº«æ©Êµo§@ªº¶¡½è©Ê»H¯Öª¢¯f¤H¤¤¡A§¿²G¤¤ªºPª«½è¤ô¥¥ý¤É°ªµM«á¤U°¡C
¡]³°¦°°¶ Ķ Á§±iºõ ®Õ¡^
We investigated the effect of epidural local anesthetic blockade on urinary substance P levels in five patients suffering from painful flare-ups of interstitial cystitis. Urine was collected in 24-h intervals commencing at the onset of an epidural bolus of 0.25% bupivacaine followed by maintenance epidural infusions of 0.05% bupivacaine. Substance P was measured by radioimmunoassay. After initiation of the epidural infusion, urinary substance P levels increased and then declined in all patients. All patients reported a decrease in pain intensity. We hypothesize that acute release, followed by depletion, of substance P from bladder sensory nerve endings accounts for the transient increase of peptide levels in urine and may contribute to the decrease in pain intensity during a 3-day epidural infusion.